CA2546846C - Method and apparatus for validation of sterilization process - Google Patents
Method and apparatus for validation of sterilization process Download PDFInfo
- Publication number
- CA2546846C CA2546846C CA2546846A CA2546846A CA2546846C CA 2546846 C CA2546846 C CA 2546846C CA 2546846 A CA2546846 A CA 2546846A CA 2546846 A CA2546846 A CA 2546846A CA 2546846 C CA2546846 C CA 2546846C
- Authority
- CA
- Canada
- Prior art keywords
- sterilization
- dose
- dosimeter
- component
- pallet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000001954 sterilising effect Effects 0.000 title claims abstract description 178
- 238000004659 sterilization and disinfection Methods 0.000 title claims abstract description 176
- 238000000034 method Methods 0.000 title claims abstract description 45
- 230000008569 process Effects 0.000 title abstract description 20
- 238000010200 validation analysis Methods 0.000 title description 15
- 238000010894 electron beam technology Methods 0.000 claims abstract description 45
- 230000005855 radiation Effects 0.000 claims abstract description 29
- 230000036512 infertility Effects 0.000 claims abstract description 21
- 238000012795 verification Methods 0.000 claims abstract description 12
- 230000002596 correlated effect Effects 0.000 claims description 18
- 230000007246 mechanism Effects 0.000 claims description 12
- 238000009826 distribution Methods 0.000 claims description 7
- 238000005259 measurement Methods 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 3
- 238000012544 monitoring process Methods 0.000 description 11
- 238000012545 processing Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000008155 medical solution Substances 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 230000032258 transport Effects 0.000 description 4
- 230000000712 assembly Effects 0.000 description 3
- 238000000429 assembly Methods 0.000 description 3
- 229940127554 medical product Drugs 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 208000032484 Accidental exposure to product Diseases 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 231100000987 absorbed dose Toxicity 0.000 description 1
- 231100000818 accidental exposure Toxicity 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000013190 sterility testing Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/26—Accessories or devices or components used for biocidal treatment
- A61L2/28—Devices for testing the effectiveness or completeness of sterilisation, e.g. indicators which change colour
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/08—Radiation
- A61L2/087—Particle radiation, e.g. electron-beam, alpha or beta radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/24—Apparatus using programmed or automatic operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/10—Apparatus features
- A61L2202/12—Apparatus for isolating biocidal substances from the environment
- A61L2202/122—Chambers for sterilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/10—Apparatus features
- A61L2202/14—Means for controlling sterilisation processes, data processing, presentation and storage means, e.g. sensors, controllers, programs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/20—Targets to be treated
- A61L2202/24—Medical instruments, e.g. endoscopes, catheters, sharps
Abstract
An apparatus, system and method for verifying the achievement of a desired sterility assurance level (SAL) for components manipulated within a low-energy electron beam sterilization chamber. The components are preferably pre-sterilized and connected together in an assembly fashion which creates and maintains the sterility of the connection by subjecting the components to low-energy (less than 300 KeV) electron beam radiation. The verification is completed by measuring the sterilization dose delivered to a sensor, also known as a dosimeter, positioned within the sterilization process to simulate the components.
Description
METHOD AND APPARATUS FOR VALIDATION OF
STERILIZATION PROCESS
Technical Field of Invention The present invention relates generally to the field of automated inspection, staging, and assembly of pre-sterilized components, specifically medical components, to maintain sterility via a low-energy electron beam field.
Background of The Invention In general, the sterilization of medical products depends upon the ability of the process to kill pathogenic microorganisms. The application of radiation to sterilize medical products is widely used throughout the world and recognized as a safe, effective form of sterilization. The first commercial application of electron beam sterilization processing for medical devices was developed by Ethicon Inc., a subsidiary of Johnson and Johnson in 1956. In the early 1960s the use of gamma rays from Cobalt-60 for the sterilization of disposable medical devices was being developed in the United Kingdom. Because of the poor reliability of the early electron beam systems, the radiation sterilization of medical products was dominated by Cobalt-60 (gamma) irradiators, which had no similar reliability issues.
With the advent of national laboratories devoted to high-energy physics research, a major effort was put into improving the reliability and performance of critical accelerator components. By the 1970s, industry's involvement in developing radiographic and oncology machines further enhanced the durability and reliability of electron accelerators.
This improvement of component performance--along with the integration of computerized controls--encouraged reevaluation of the commercial possibilities of the technology. Soon thereafter, interest in high-energy (>300 keV) E-beam based sterilization was rapidly growing.
Perhaps the largest industrial application of radiation is the modification of polymers.
Radiation is used to polymerize and cure monomers into polymers, to cross-link polymers, and to graft different types of monomers onto polymer molecules to form new materials with special properties. Radiation is also used for the intentional degradation of polymers and for tailoring of molecular weight distributions to serve special industrial and commercial purposes. This industrial application of radiation is dominated by low energy (<300 keV) electron beam systems.
In 1999, use of a low-energy (<300 KeV) E-beam system in sterilization of medical devices was described in U.S. Patent No. 7,264,771, assigned to Baxter International. E-beam sterilization unit size and cost were two big factors feeding the move toward low-energy sterilization systems. Depth of the sterilizing radiation penetration became the trade-off. Where high-energy systems may achieve penetration depths of over a meter, low-energy beams are limited to penetration depths of as low as only a few microns.
The significantly reduced radiation penetration of low-energy electron beams used for medical device sterilization raised the issue of sterility validation as a processing concern. The FDA requires that "all processes used to produce medical devices be validated" (21 C.F.R. 820.752), including E-beam sterilization. The goal of such validation is to determine the minimum exposure dose that can be used to meet a desired sterility assurance level and allow "dosimetric release," which is the determination that a product is sterile based on physical irradiation process data rather than actual sterility testing.
Therefore, validation must begin with the selection of a sterility assurance level (SAL), a measure of the probability that one unit in a batch will remain non-sterile after being exposed to a specific sterilant. For example, an SAL of 10'9 means that one device in a thousand may be non-sterile. Selecting the proper SAL occurs during a dose-setting phase of radiation sterilization validation. In many cases, the intended use of the device will dictate the need for a particular SAL. The commonly accepted SAL for invasive medical devices' is 10.6. However, some European countries only recognize 10' SAL for a claim of "sterile," In such cases, the country of intended use will dictate the SAL as much as the device's intended use.
Although both gamma and ethylene oxidegas sterilization are validated, effective and readily available technologies, the increased focus on E-beam can be ascribed to its having the shortest process cycle of any currently recognized sterilization method. In both high- and low-energy E-beam processing, the products are scanned for seconds, with the bulk of the processing time devoted to transporting the products into and out of a shielded booth, With the use of established and recognized dosimetric release procedures, a product under going high-energy E-beam sterilization can be released from quarantine as sterile within 30 minutes. The prior art, however, has not sufficiently developed a method for validation and routine monitoring of low-energy E-beam sterilization.
As a solution to this problem, the present invention has been developed which provides an apparatus for use in the validation of low-energy electron beam sterilization systems. Furthermore, the invention provides a method that cost-effectively and reliably provides for the routine dosimetric monitoring of the sterilization process for low-energy electron beam sterilization systems.
Summary of The Invention Generally, the present invention comprises a method and apparatus for verifying the radiation dose delivered to achieve the sterilization of components, such as medical devices, in a low-energy electron beam sterilization system.
Specifically, as one embodiment of the present invention, a single-site dosimeter assembly is disclosed. The assembly is comprised of a first component block having a cavity, suitable for positioning a dosimeter therein, and a coaxially configured passage to allow for the travel of radiation into the cavity portion. A second component block affixes to the first block and comprises an interior surface with a protrusion configured to abut an interior surface of the cavity, thereby retaining the dosimeter therein. The assembly may further comprise a mechanism to affix the first dosimeter block to the second dosimeter block, and affix the resulting assembly to aradiation sterilization site.
A method for verifying sterilization of components in a low-energy electron-beam sterilization system is also described. The novel method comprises the steps of placing a component within a low-energy electron-beam sterilization system as a site to be sterilized, designating an indicator site within the sterilization system as a site to be used to indicate achievement of a dose level, determining a sterilization dose level which when achieved results in a desired sterility assurance level (SAL) of a component, establishing a correlation between a dose achieved at the indicator site and a dose achieved at the sterilization site, exposing the designated sites to a sterilizing source to achieve a sterilization dose at the sterilization site and a correlated dose at the indicator site, determining the dose achieved at the indicator site, and ascertaining the efficacy of the sterilization dose achieved at the sterilization site based on the determined dose at the correlated indicator site.
In one embodiment of the disclosed method, the step of establishing a correlation comprises the steps of exposing the designated sites to a sterilizing source to mimic operation of a sterilization system, measuring the sterilizing dose received at each site, and repeating exposing and measuring steps to determine a relationship between the sterilizing dose level measured at a sterilizing site and a sterilizing dose level measured at an indication site.
An assembly capable of verifying sterilization of two components to be connected together is also disclosed. The assembly comprises a first component carriage and a second component carriage. Each carriage preferably comprises a component site requiring a threshold sterilization dose to achieve sterility of a component, and a dosimeter site positioned approximate the component site and having a dosimeter to receive an applied dose which corresponds to a sterilization dose level received by the component site.
It is important to note that the does ultimately achieved at the indicator site is not necessarily equal to that achieved at the sterilization site, nor is it necessary that the dose at the indicator site even be a sterilizing dose.
In an embodiment of the assembly, the first component carriage further comprises a mechanism to control the sterilization dose received by the dosimeter at the dosimeter site.
The mechanism in one embodiment comprises a passage having a diameter and a depth, with the passage being positioned above the dosimeter site. The diameter and depth of the passage may be of any suitable sizes to allow for the proper amount of radiation exposure.
The assembled dosimeter site preferably comprises a first holder block having a receptacle defined within a wall of the holder block to contain a dosimeter therein, and a passage, having a diameter and depth, through the wall within the periphery of the receptacle, and a second holder block configured with a mating section which fits within the receptacle of the first holder block to abut the dosimeter therein.
The first component carriage may comprise from 1 to 10 component sites and from 1 to 15 dosimeter sites.
-4a-In another aspect of the present invention there is provided a method for verifying sterilization of components in a sterilization system using a low-energy electron beam comprising the steps of:
determining a minimum sterilization dose which when applied to a sample of a component results in a desired sterility assurance level (SAL) of less than about 10-3;
exposing a sample component and a plurality of indicators to the low-energy electron beam;
measuring a sterilization dose received at each indicator, at least one of the plurality of indicators providing a sterilization dose measurement indicative of the sterilization dose at the sample component;
determining a dose distribution of the sample component;
establishing a correlation between the sterilization dose at the sample component and the sterilization dose measured at at least one of the plurality of indicators;
placing a component to be sterilized onto a component pallet;
attaching by a mechanism a holder containing a correlated indicator therein to the component pallet as a site to be used to indicate achievement of at least the minimum sterilization dose;
exposing the component and correlated indicator to the low-energy electron beam;
determining the sterilization dose at the indicator; and ascertaining the efficacy of the sterilization dose achieved at the component based on the determined sterilization dose at the correlated indicator.
In yet another aspect of the present invention there is provided a system for verifying the sterility of components comprising:
a sterilization chamber;
a pallet member configured to position a component within the sterilization chamber;
a dosimeter holder having a plurality of dosimeters contained therein, the dosimeter holder detachably affixed to the pallet member by a mechanism and including a plurality of passages permitting radiation to reach the plurality of contained dosimeters;
-4b-a low-energy sterilization source configured to deliver a sterilization dose to a component and a correlated dose to the dosimeter within the sterilization chamber, wherein the sterilization dose results in a desired sterility assurance level ("SAL") of less than about 10-3;
a verification station located apart from the sterilization chamber at which the dosimeter holder is removed from the pallet member and the dosimeter holder is disassembled to gain access to the plurality of dosimeters for measuring the correlated dose absorbed by the plurality of dosimeters within the sterilization chamber; and wherein the sterilization chamber, the pallet member, the dosimeter holder, the low to energy sterilization source, and the verification station are configured and arranged to enable the correlated dose to be determined by (i) exposing a sample component and the plurality of dosimeters to the low-energy sterilization source, (ii) measuring a sterilization dose received at each dosimeter, at least one of the plurality of dosimeters providing a sterilization dose measurement indicative of the sterilization dose at the sample component, (iii) determining a dose distribution of the sample component, and (iv) establishing a correlation between the sterilization dose at the sample component and the sterilization dose measured at the at least one of the plurality of dosimeters.
These and other features are provided in the present invention. A more detailed description of the several components, their purposes, and possible alternative embodiments are set forth in the detailed discussion following:
Brief Description of The Drawings The details of the present invention can be more readily understood when the flowing description is considered in combination with the appended drawings where:
STERILIZATION PROCESS
Technical Field of Invention The present invention relates generally to the field of automated inspection, staging, and assembly of pre-sterilized components, specifically medical components, to maintain sterility via a low-energy electron beam field.
Background of The Invention In general, the sterilization of medical products depends upon the ability of the process to kill pathogenic microorganisms. The application of radiation to sterilize medical products is widely used throughout the world and recognized as a safe, effective form of sterilization. The first commercial application of electron beam sterilization processing for medical devices was developed by Ethicon Inc., a subsidiary of Johnson and Johnson in 1956. In the early 1960s the use of gamma rays from Cobalt-60 for the sterilization of disposable medical devices was being developed in the United Kingdom. Because of the poor reliability of the early electron beam systems, the radiation sterilization of medical products was dominated by Cobalt-60 (gamma) irradiators, which had no similar reliability issues.
With the advent of national laboratories devoted to high-energy physics research, a major effort was put into improving the reliability and performance of critical accelerator components. By the 1970s, industry's involvement in developing radiographic and oncology machines further enhanced the durability and reliability of electron accelerators.
This improvement of component performance--along with the integration of computerized controls--encouraged reevaluation of the commercial possibilities of the technology. Soon thereafter, interest in high-energy (>300 keV) E-beam based sterilization was rapidly growing.
Perhaps the largest industrial application of radiation is the modification of polymers.
Radiation is used to polymerize and cure monomers into polymers, to cross-link polymers, and to graft different types of monomers onto polymer molecules to form new materials with special properties. Radiation is also used for the intentional degradation of polymers and for tailoring of molecular weight distributions to serve special industrial and commercial purposes. This industrial application of radiation is dominated by low energy (<300 keV) electron beam systems.
In 1999, use of a low-energy (<300 KeV) E-beam system in sterilization of medical devices was described in U.S. Patent No. 7,264,771, assigned to Baxter International. E-beam sterilization unit size and cost were two big factors feeding the move toward low-energy sterilization systems. Depth of the sterilizing radiation penetration became the trade-off. Where high-energy systems may achieve penetration depths of over a meter, low-energy beams are limited to penetration depths of as low as only a few microns.
The significantly reduced radiation penetration of low-energy electron beams used for medical device sterilization raised the issue of sterility validation as a processing concern. The FDA requires that "all processes used to produce medical devices be validated" (21 C.F.R. 820.752), including E-beam sterilization. The goal of such validation is to determine the minimum exposure dose that can be used to meet a desired sterility assurance level and allow "dosimetric release," which is the determination that a product is sterile based on physical irradiation process data rather than actual sterility testing.
Therefore, validation must begin with the selection of a sterility assurance level (SAL), a measure of the probability that one unit in a batch will remain non-sterile after being exposed to a specific sterilant. For example, an SAL of 10'9 means that one device in a thousand may be non-sterile. Selecting the proper SAL occurs during a dose-setting phase of radiation sterilization validation. In many cases, the intended use of the device will dictate the need for a particular SAL. The commonly accepted SAL for invasive medical devices' is 10.6. However, some European countries only recognize 10' SAL for a claim of "sterile," In such cases, the country of intended use will dictate the SAL as much as the device's intended use.
Although both gamma and ethylene oxidegas sterilization are validated, effective and readily available technologies, the increased focus on E-beam can be ascribed to its having the shortest process cycle of any currently recognized sterilization method. In both high- and low-energy E-beam processing, the products are scanned for seconds, with the bulk of the processing time devoted to transporting the products into and out of a shielded booth, With the use of established and recognized dosimetric release procedures, a product under going high-energy E-beam sterilization can be released from quarantine as sterile within 30 minutes. The prior art, however, has not sufficiently developed a method for validation and routine monitoring of low-energy E-beam sterilization.
As a solution to this problem, the present invention has been developed which provides an apparatus for use in the validation of low-energy electron beam sterilization systems. Furthermore, the invention provides a method that cost-effectively and reliably provides for the routine dosimetric monitoring of the sterilization process for low-energy electron beam sterilization systems.
Summary of The Invention Generally, the present invention comprises a method and apparatus for verifying the radiation dose delivered to achieve the sterilization of components, such as medical devices, in a low-energy electron beam sterilization system.
Specifically, as one embodiment of the present invention, a single-site dosimeter assembly is disclosed. The assembly is comprised of a first component block having a cavity, suitable for positioning a dosimeter therein, and a coaxially configured passage to allow for the travel of radiation into the cavity portion. A second component block affixes to the first block and comprises an interior surface with a protrusion configured to abut an interior surface of the cavity, thereby retaining the dosimeter therein. The assembly may further comprise a mechanism to affix the first dosimeter block to the second dosimeter block, and affix the resulting assembly to aradiation sterilization site.
A method for verifying sterilization of components in a low-energy electron-beam sterilization system is also described. The novel method comprises the steps of placing a component within a low-energy electron-beam sterilization system as a site to be sterilized, designating an indicator site within the sterilization system as a site to be used to indicate achievement of a dose level, determining a sterilization dose level which when achieved results in a desired sterility assurance level (SAL) of a component, establishing a correlation between a dose achieved at the indicator site and a dose achieved at the sterilization site, exposing the designated sites to a sterilizing source to achieve a sterilization dose at the sterilization site and a correlated dose at the indicator site, determining the dose achieved at the indicator site, and ascertaining the efficacy of the sterilization dose achieved at the sterilization site based on the determined dose at the correlated indicator site.
In one embodiment of the disclosed method, the step of establishing a correlation comprises the steps of exposing the designated sites to a sterilizing source to mimic operation of a sterilization system, measuring the sterilizing dose received at each site, and repeating exposing and measuring steps to determine a relationship between the sterilizing dose level measured at a sterilizing site and a sterilizing dose level measured at an indication site.
An assembly capable of verifying sterilization of two components to be connected together is also disclosed. The assembly comprises a first component carriage and a second component carriage. Each carriage preferably comprises a component site requiring a threshold sterilization dose to achieve sterility of a component, and a dosimeter site positioned approximate the component site and having a dosimeter to receive an applied dose which corresponds to a sterilization dose level received by the component site.
It is important to note that the does ultimately achieved at the indicator site is not necessarily equal to that achieved at the sterilization site, nor is it necessary that the dose at the indicator site even be a sterilizing dose.
In an embodiment of the assembly, the first component carriage further comprises a mechanism to control the sterilization dose received by the dosimeter at the dosimeter site.
The mechanism in one embodiment comprises a passage having a diameter and a depth, with the passage being positioned above the dosimeter site. The diameter and depth of the passage may be of any suitable sizes to allow for the proper amount of radiation exposure.
The assembled dosimeter site preferably comprises a first holder block having a receptacle defined within a wall of the holder block to contain a dosimeter therein, and a passage, having a diameter and depth, through the wall within the periphery of the receptacle, and a second holder block configured with a mating section which fits within the receptacle of the first holder block to abut the dosimeter therein.
The first component carriage may comprise from 1 to 10 component sites and from 1 to 15 dosimeter sites.
-4a-In another aspect of the present invention there is provided a method for verifying sterilization of components in a sterilization system using a low-energy electron beam comprising the steps of:
determining a minimum sterilization dose which when applied to a sample of a component results in a desired sterility assurance level (SAL) of less than about 10-3;
exposing a sample component and a plurality of indicators to the low-energy electron beam;
measuring a sterilization dose received at each indicator, at least one of the plurality of indicators providing a sterilization dose measurement indicative of the sterilization dose at the sample component;
determining a dose distribution of the sample component;
establishing a correlation between the sterilization dose at the sample component and the sterilization dose measured at at least one of the plurality of indicators;
placing a component to be sterilized onto a component pallet;
attaching by a mechanism a holder containing a correlated indicator therein to the component pallet as a site to be used to indicate achievement of at least the minimum sterilization dose;
exposing the component and correlated indicator to the low-energy electron beam;
determining the sterilization dose at the indicator; and ascertaining the efficacy of the sterilization dose achieved at the component based on the determined sterilization dose at the correlated indicator.
In yet another aspect of the present invention there is provided a system for verifying the sterility of components comprising:
a sterilization chamber;
a pallet member configured to position a component within the sterilization chamber;
a dosimeter holder having a plurality of dosimeters contained therein, the dosimeter holder detachably affixed to the pallet member by a mechanism and including a plurality of passages permitting radiation to reach the plurality of contained dosimeters;
-4b-a low-energy sterilization source configured to deliver a sterilization dose to a component and a correlated dose to the dosimeter within the sterilization chamber, wherein the sterilization dose results in a desired sterility assurance level ("SAL") of less than about 10-3;
a verification station located apart from the sterilization chamber at which the dosimeter holder is removed from the pallet member and the dosimeter holder is disassembled to gain access to the plurality of dosimeters for measuring the correlated dose absorbed by the plurality of dosimeters within the sterilization chamber; and wherein the sterilization chamber, the pallet member, the dosimeter holder, the low to energy sterilization source, and the verification station are configured and arranged to enable the correlated dose to be determined by (i) exposing a sample component and the plurality of dosimeters to the low-energy sterilization source, (ii) measuring a sterilization dose received at each dosimeter, at least one of the plurality of dosimeters providing a sterilization dose measurement indicative of the sterilization dose at the sample component, (iii) determining a dose distribution of the sample component, and (iv) establishing a correlation between the sterilization dose at the sample component and the sterilization dose measured at the at least one of the plurality of dosimeters.
These and other features are provided in the present invention. A more detailed description of the several components, their purposes, and possible alternative embodiments are set forth in the detailed discussion following:
Brief Description of The Drawings The details of the present invention can be more readily understood when the flowing description is considered in combination with the appended drawings where:
FIGURE 1 is a perspective view of the backside of a bag sterilization pallet having attached thereto one embodiment of the present dosimeter'holder of the present invention;
FIGURE 2 is a back elevation view showing an embodiment of the present invention attached to the bag sterilization pallet of FIGURE 1;
FIGURE 3 is a top view showing one embodiment of a multi-site dosimeter holder attached to the bag sterilization pallet of FIGURE 1;
FIGURE 4 is a side elevated view of one embodiment of a dosimeter holder attached to the bag sterilization pallet of FIGURE 1, including a medical solution bag and vial/device shown;
FIGURE 5 is an exploded view of one embodiment of a multi-site dosimeter holder of the present invention;
FIGURE 6 is a cross-sectional view of the assembled embodiment of the dosimeter holder shown in FIGURE 5;
FIGURE 7 is a plan view of the second or upper block of the embodiment shown in FIGURE 6;
FIGURE 8 is a plan view of the first or lower block of the embodiment shown in FIGURE 6;
FIGURE 9 is a perspective view of one embodiment of a vial/device pallet having attached thereto another embodiment of a multi-site dosimeter holder of the present invention;
FIGURE 10 is a side elevation view showing an embodiment of a multi-site dosimeter holder attached to the vial/device pallet of FIGURE 9, including a device and drug vial shown connected;
FIGURE 11 is a front view showing one embodiment of a multi-site dosimeter holder attached to the vial/device pallet of FIGURE 9;
FIGURE 12 is a top plan view of one embodiment of a multi-site dosimeter holder attached to the vial/device pallet of FIGURE 9;
FIGURE 13 is a perspective view of one embodiment of a second or lower block of a single-site dosimeter holder;
FIGURE 14 is a perspective view of one embodiment of a first or upper block of a single-site dosimeter holder;
FIGURE 15 is an exploded view of another embodiment of a multi-site dosimeter holder for use on the device side of the vial/device pallet of FIGURE 9;
FIGURE 2 is a back elevation view showing an embodiment of the present invention attached to the bag sterilization pallet of FIGURE 1;
FIGURE 3 is a top view showing one embodiment of a multi-site dosimeter holder attached to the bag sterilization pallet of FIGURE 1;
FIGURE 4 is a side elevated view of one embodiment of a dosimeter holder attached to the bag sterilization pallet of FIGURE 1, including a medical solution bag and vial/device shown;
FIGURE 5 is an exploded view of one embodiment of a multi-site dosimeter holder of the present invention;
FIGURE 6 is a cross-sectional view of the assembled embodiment of the dosimeter holder shown in FIGURE 5;
FIGURE 7 is a plan view of the second or upper block of the embodiment shown in FIGURE 6;
FIGURE 8 is a plan view of the first or lower block of the embodiment shown in FIGURE 6;
FIGURE 9 is a perspective view of one embodiment of a vial/device pallet having attached thereto another embodiment of a multi-site dosimeter holder of the present invention;
FIGURE 10 is a side elevation view showing an embodiment of a multi-site dosimeter holder attached to the vial/device pallet of FIGURE 9, including a device and drug vial shown connected;
FIGURE 11 is a front view showing one embodiment of a multi-site dosimeter holder attached to the vial/device pallet of FIGURE 9;
FIGURE 12 is a top plan view of one embodiment of a multi-site dosimeter holder attached to the vial/device pallet of FIGURE 9;
FIGURE 13 is a perspective view of one embodiment of a second or lower block of a single-site dosimeter holder;
FIGURE 14 is a perspective view of one embodiment of a first or upper block of a single-site dosimeter holder;
FIGURE 15 is an exploded view of another embodiment of a multi-site dosimeter holder for use on the device side of the vial/device pallet of FIGURE 9;
FIGURE 16 is a cross-section of a multi-site dosimeter holder for attachment to the vial/device pallet shown in FIGURE 9;
FIGURE 17 is a top view of one embodiment of a second or upper block of a multi-site dosimeter holder of the present invention;
FIGURE 18 is a top view of one embodiment of a first or lower block of a multi-site dosimeter holder of the present invention;
FIGURES 19(a) and 19(b) are perspective views (underside and topside, respectively) of the assembled single-site dosimeter holder shown in FIGURES
13 and 14;
FIGURES 20A-C are schematics of a sterilization booth illustrating the sequencing of chamber door openings to move pallets through the sterilization process;
FIGURES 21 and 22 are cut away views of the internal components of the bag sterilization chamber; and, FIGURE 23 is a cut away side view of a vial/device sterilization booth.
Detailed Description of The Invention While the present invention is susceptible of embodiment in many different forms, this disclosure will describe in detail at least one preferred embodiment, and possible alternative embodiments, of the invention with the understanding that the present disclosure is to be considered merely as an exemplification of the principles of the invention and is not intended to limit the broad aspect of the invention to the specific embodiments illustrated.
The present invention provides an assembly for verification of low-energy e-beam sterilization, as well as methods of using the same. For purposes of the present application, the following definitions of terms are used:
Sterility (Sterilize, Sterilization, etc.,), the act of using or condition achieved after use of a physical or chemical procedure to destroy microbial life, including pathogens such as highly resistant bacterial endospores and viruses;
Sterility assurance level (SAL), a measure of the probability that one unit in a batch will remain non-sterile after being exposed to a specific sterilant;
Low-Energy Electron-Beam, an electron beam or beam array which operates at an energy of less than 300 KeV, more preferably in the range of from about 60 to about 150 KeV;
Validation of Sterilization, a process for determining that exposure to a specific dose or level of radiation will result in a desired sterility assurance level (SAL);
FIGURE 17 is a top view of one embodiment of a second or upper block of a multi-site dosimeter holder of the present invention;
FIGURE 18 is a top view of one embodiment of a first or lower block of a multi-site dosimeter holder of the present invention;
FIGURES 19(a) and 19(b) are perspective views (underside and topside, respectively) of the assembled single-site dosimeter holder shown in FIGURES
13 and 14;
FIGURES 20A-C are schematics of a sterilization booth illustrating the sequencing of chamber door openings to move pallets through the sterilization process;
FIGURES 21 and 22 are cut away views of the internal components of the bag sterilization chamber; and, FIGURE 23 is a cut away side view of a vial/device sterilization booth.
Detailed Description of The Invention While the present invention is susceptible of embodiment in many different forms, this disclosure will describe in detail at least one preferred embodiment, and possible alternative embodiments, of the invention with the understanding that the present disclosure is to be considered merely as an exemplification of the principles of the invention and is not intended to limit the broad aspect of the invention to the specific embodiments illustrated.
The present invention provides an assembly for verification of low-energy e-beam sterilization, as well as methods of using the same. For purposes of the present application, the following definitions of terms are used:
Sterility (Sterilize, Sterilization, etc.,), the act of using or condition achieved after use of a physical or chemical procedure to destroy microbial life, including pathogens such as highly resistant bacterial endospores and viruses;
Sterility assurance level (SAL), a measure of the probability that one unit in a batch will remain non-sterile after being exposed to a specific sterilant;
Low-Energy Electron-Beam, an electron beam or beam array which operates at an energy of less than 300 KeV, more preferably in the range of from about 60 to about 150 KeV;
Validation of Sterilization, a process for determining that exposure to a specific dose or level of radiation will result in a desired sterility assurance level (SAL);
Verification of Sterility, a process for determining that a desired component was exposed to the proper amount of radiation to achieve sterility;
Dosimeter, any device that, when irradiated, exhibits a quantifiable change in some property of the device that can be related to absorbed dose in a given material using appropriate analytical instrumentation and techniques;
Component, any medical device capable of being sterilized, such as, for example, drug vial, syringe, reconstitution device, medical tubing, IV bag, cannula, and the like; and Pallet (or Carriage), a device configured for the housing, transport, and, in some cases, shielding of components in a sterilization process, particularly a sterile connection process.
The prior art discloses methods and apparatus for the verification of ultraviolet sterilization (U.S. Patent No. 6,475,433 to McGeorge et al.) and thermal sterilization (U.S.
Patent No. 6,340,590 to Gillis). Verification of sterilization in a low-energy electron beam system, however, provides far different challenges to those skilled in the art, as the following specification will address.
Accordingly, the present invention involves methods and apparatus for automatically verifying sterilization of components, particularly where two or more components are to be connected in a sterile field. While the components may be made from any known material, preferably the objects are made from a readily sterilizable material. For example, a glass drug vial may be sterilely connected to a rigid plastic reconstitution device to form a vial/device assembly (VDA). The assembly may then be sterile-connected to.a flexible tubing portion of a fluid bag to form a final assembly. Such a vial/device assembly (VDA) and final assembly are shown in the appended drawings and described herein.
However, the claimed invention should not be limited to these embodiments, which are included for exemplary purposes only.
After being pre-sterilized, the components are received into a sterilization pallet utilizing the present invention for verification. Sterilization pallets are used to house, transport, and, in some cases, shield portions of the components as they move within a sterilization system. Such pallets maybe specifically designed for containing a single-sized component, such as a reconstitution device, or may be adjustable for varying sizes of a component, such as drug vials. Referring generally to FIGURES 1-18, some example sterilization pallets can be seen.
Dosimeter, any device that, when irradiated, exhibits a quantifiable change in some property of the device that can be related to absorbed dose in a given material using appropriate analytical instrumentation and techniques;
Component, any medical device capable of being sterilized, such as, for example, drug vial, syringe, reconstitution device, medical tubing, IV bag, cannula, and the like; and Pallet (or Carriage), a device configured for the housing, transport, and, in some cases, shielding of components in a sterilization process, particularly a sterile connection process.
The prior art discloses methods and apparatus for the verification of ultraviolet sterilization (U.S. Patent No. 6,475,433 to McGeorge et al.) and thermal sterilization (U.S.
Patent No. 6,340,590 to Gillis). Verification of sterilization in a low-energy electron beam system, however, provides far different challenges to those skilled in the art, as the following specification will address.
Accordingly, the present invention involves methods and apparatus for automatically verifying sterilization of components, particularly where two or more components are to be connected in a sterile field. While the components may be made from any known material, preferably the objects are made from a readily sterilizable material. For example, a glass drug vial may be sterilely connected to a rigid plastic reconstitution device to form a vial/device assembly (VDA). The assembly may then be sterile-connected to.a flexible tubing portion of a fluid bag to form a final assembly. Such a vial/device assembly (VDA) and final assembly are shown in the appended drawings and described herein.
However, the claimed invention should not be limited to these embodiments, which are included for exemplary purposes only.
After being pre-sterilized, the components are received into a sterilization pallet utilizing the present invention for verification. Sterilization pallets are used to house, transport, and, in some cases, shield portions of the components as they move within a sterilization system. Such pallets maybe specifically designed for containing a single-sized component, such as a reconstitution device, or may be adjustable for varying sizes of a component, such as drug vials. Referring generally to FIGURES 1-18, some example sterilization pallets can be seen.
FIGURES 1-4 illustrate a bag pallet 70a. FIGURES 9-12 illustrate a vial and device pallet 70b. The bag pallet 70a is preferably a metal structure which functions to maintain at least one bag component in position for connection to at least one other component while at least a portion of those components are maintained within an electron beam field. Likewise, the vial and device pallet 70b is preferably a substantially metal structure that also functions to position components for connection while being maintained within an electron beam field.
In the case of both pallets, it is also a function to shield portions of the components from the electron beam field during connection. As those skilled in the art would understand, the physical form of the pallets depends on many factors, including, for example, the dimensions of the components being connected, the connection strategy, etc. A further description of these pallet devices is more fully set forth in U.S. Patent No. 7,358,505, assigned to Baxter International.
In the present invention, the bag pallet 70a is generally designed to grip and retain, via grippers 75, the tubing of as many as four medical solution bags (SB) and four vial/device assemblies (VDA) (see FIGURE 4), as Illustrated in FIGURE 1. In this position the open end of the tubing of each medical solution bag (SB) would be aligned with an end of one of the vial/device assemblies (VDA). While these components are pre-sterilized, it is desired to make the connection between the tubing end and the vial/device in a manner that maintains the sterility. Referring to FIGURES 3 and 4, the position on the pallet 70a where the component resides is called the component site 73. Specifically, the position of the component end (the portion of the component to be connected) determines the component site 73. In the present embodiment, the ends of the two components to be connected together are maintained in such close proximity to one another that only a single component site 73 exists for each component pair. However, alternate configurations are possible.
Referring generally to the vial and device pallet of FIGURES 9-12, four cartridges 77 are shown configured to carry reconstitution devices (RD), while the vial holder 71 is shown to be configured to contain four inverted drug vials, It is similarly desirable to create a sterile connection between these components to create four complete vial/device assemblies (VDA) for later use in connecting to a sterile medical solution bag. Additional pallet designs may be contemplated for carrying other medical components for sterilization, Returning to FIGURES 1-4, each pallet is designed to expose the retained components to the active sterile field created by the low-energy electron beam. Bag pallet 70a permits the sterilizing electron beam to pass through a window 41.
Typically, as in the present invention, where more than a single e-beam tube is used to address shadowing, or where a particular component or component contents may be especially susceptible to degradation from electron beam exposure, additional separate shielding (not shown) may be provided in the sterilization booth for the exposed portions of, for example, the bag (SB) and vial/device assembly (VDA). Ideally, only the connecting ends of the components (i.e., the portions within component sites 73) are to be exposed to the electron beam field. The remaining portion of the components is preferably shielded by either the pallet or an alternative means within the sterilization booth.
In the present embodiment, while the component site 73 is exposed to the beam field, the component ends are then connected together through the actuation of at least one of the components toward the other component. Movement of the components should be limited to the constraints of the electron-beam field until a proper connection is completed.
A key aspect of the present invention is the ability to initially validate sterilization of exposed components at a specific dose level. It is a further feature of the invention to provide routine dose monitoring of the sterilization process.
The use of routine radiation monitoring devices such as dosimeters for processing have been used for many years and are widely recognized and understood in the industry.
However, all of the routine monitoring dosimeter fixtures and processes used are based on the premise that the radiation source penetrates the dosimeter, its packaging, and in many cases, a fixture. This premise is based on the fact that such radiation sterilization applications involve the use of penetrating radioisotopes or high energy electrons. Due to the deep-penetrating ability of this matter, precise placement of dosimeters is not as critical nor is the direct exposure from the radiation source to the dosimeter.
The present embodiment of the invention, however, utilizes "non-penetrating"
(in a relative sense) low-energy electrons. A monitoring fixture has been designed to work in the low-energy process where direct exposure of the dosimeter is necessary. In one preferred embodiment of the invention, the dosimeter is a radiochromic film. In addition to exposing the radiochromic film directly to the electron beam, the monitoring fixture is placed such that the dose to which the dosimeter film is exposed will be approximately relative to the dose the product receives. The dosimeter placement is referred to as the indicator site.
In the case of both pallets, it is also a function to shield portions of the components from the electron beam field during connection. As those skilled in the art would understand, the physical form of the pallets depends on many factors, including, for example, the dimensions of the components being connected, the connection strategy, etc. A further description of these pallet devices is more fully set forth in U.S. Patent No. 7,358,505, assigned to Baxter International.
In the present invention, the bag pallet 70a is generally designed to grip and retain, via grippers 75, the tubing of as many as four medical solution bags (SB) and four vial/device assemblies (VDA) (see FIGURE 4), as Illustrated in FIGURE 1. In this position the open end of the tubing of each medical solution bag (SB) would be aligned with an end of one of the vial/device assemblies (VDA). While these components are pre-sterilized, it is desired to make the connection between the tubing end and the vial/device in a manner that maintains the sterility. Referring to FIGURES 3 and 4, the position on the pallet 70a where the component resides is called the component site 73. Specifically, the position of the component end (the portion of the component to be connected) determines the component site 73. In the present embodiment, the ends of the two components to be connected together are maintained in such close proximity to one another that only a single component site 73 exists for each component pair. However, alternate configurations are possible.
Referring generally to the vial and device pallet of FIGURES 9-12, four cartridges 77 are shown configured to carry reconstitution devices (RD), while the vial holder 71 is shown to be configured to contain four inverted drug vials, It is similarly desirable to create a sterile connection between these components to create four complete vial/device assemblies (VDA) for later use in connecting to a sterile medical solution bag. Additional pallet designs may be contemplated for carrying other medical components for sterilization, Returning to FIGURES 1-4, each pallet is designed to expose the retained components to the active sterile field created by the low-energy electron beam. Bag pallet 70a permits the sterilizing electron beam to pass through a window 41.
Typically, as in the present invention, where more than a single e-beam tube is used to address shadowing, or where a particular component or component contents may be especially susceptible to degradation from electron beam exposure, additional separate shielding (not shown) may be provided in the sterilization booth for the exposed portions of, for example, the bag (SB) and vial/device assembly (VDA). Ideally, only the connecting ends of the components (i.e., the portions within component sites 73) are to be exposed to the electron beam field. The remaining portion of the components is preferably shielded by either the pallet or an alternative means within the sterilization booth.
In the present embodiment, while the component site 73 is exposed to the beam field, the component ends are then connected together through the actuation of at least one of the components toward the other component. Movement of the components should be limited to the constraints of the electron-beam field until a proper connection is completed.
A key aspect of the present invention is the ability to initially validate sterilization of exposed components at a specific dose level. It is a further feature of the invention to provide routine dose monitoring of the sterilization process.
The use of routine radiation monitoring devices such as dosimeters for processing have been used for many years and are widely recognized and understood in the industry.
However, all of the routine monitoring dosimeter fixtures and processes used are based on the premise that the radiation source penetrates the dosimeter, its packaging, and in many cases, a fixture. This premise is based on the fact that such radiation sterilization applications involve the use of penetrating radioisotopes or high energy electrons. Due to the deep-penetrating ability of this matter, precise placement of dosimeters is not as critical nor is the direct exposure from the radiation source to the dosimeter.
The present embodiment of the invention, however, utilizes "non-penetrating"
(in a relative sense) low-energy electrons. A monitoring fixture has been designed to work in the low-energy process where direct exposure of the dosimeter is necessary. In one preferred embodiment of the invention, the dosimeter is a radiochromic film. In addition to exposing the radiochromic film directly to the electron beam, the monitoring fixture is placed such that the dose to which the dosimeter film is exposed will be approximately relative to the dose the product receives. The dosimeter placement is referred to as the indicator site.
Three different sterilization validation and routine monitoring dosimeter fixtures are shown in the appended drawing figures. FIGURES 13 and 14 illustrate different halves of a basic single-site dosimeter holder 10, while the assembled fixture is shown in FIGURES
19(a) and 19(b). FIGURES 5-8 illustrate a multi-site dosimeter holder 40(a) for attachment to the bag pallet 70a of FIGURES 1-4. FIGURES 15-18 illustrate a multi-site dosimeter holder 40(b) for attachment to the vial and device pallet 70b of FIGURES 9-12.
Generally speaking, the respective dosimeter holder or fixtures shown are each comprised of a basic plate configured to be attached to a pallet-either a bag pallet or vialldevice pallet. The plate can be a single metal plate or devised of any number of connectable parts. It may to house as few as a single dosimeter, such as a dosimeter film, or a plurality of such devices for a particular holder.
Referring to FIGURES 13, 14 and 19, halves of the single-site dosimeter holder are shown. The holder 10 (when assembled) is comprised of a first dosimeter block 12 (FIGURE 14) and a second dosimeter block 14 (FIGURE 13). The first block 12 comprises an interior surface 16 with a substantially square cavity 18 defined therein, and an outer surface 20 with a cylindrical passage 22 to the cavity 18 passing therethrough. The cavity 18 may be of any desired shape to accommodate a radiochromic film dosimeter, which typically comes as a small square piece-though other shapes and sizes may be more suitable for alternative embodiments. The embodiment of FIGURE 14 also illustrates four radiused corner notches 24 extending from the cavity 18. These notches 24 facilitate the removal of the radiochromic film dosimeter from the cavity 18. The passage 22 may also be machined to various shapes, if desired. In alternative embodiments, the passage 22 may be in the second dosimeter block 14 or pass through an adjacent side of the dosimeter block.
In the present embodiment, the second dosimeter block 14 of FIGURE 13 comprises an interior surface 26 with a protrusion 28 configured to abut an interior surface of the cavity 18 of block 12. In use, a radiochromic film dosimeter 30 is positioned within the cavity 18 of the first block 12 and held in place by the protrusion 28 of the second block 14.
A first mechanism (not shown), such as a pin, bolt, or similar device, is used to pass through aperture 79 to affix the first dosimeter block 12 to the second dosimeter block 14 to form a dosimeter holder or assembly 10 (FIGURE 19). Additionally, a second mechanism (not shown) may be used to affix the holder 10 to a radiation sterilization site, such as a component pallet. The first mechanism may perform the operation of the second mechanism for certain applications.
19(a) and 19(b). FIGURES 5-8 illustrate a multi-site dosimeter holder 40(a) for attachment to the bag pallet 70a of FIGURES 1-4. FIGURES 15-18 illustrate a multi-site dosimeter holder 40(b) for attachment to the vial and device pallet 70b of FIGURES 9-12.
Generally speaking, the respective dosimeter holder or fixtures shown are each comprised of a basic plate configured to be attached to a pallet-either a bag pallet or vialldevice pallet. The plate can be a single metal plate or devised of any number of connectable parts. It may to house as few as a single dosimeter, such as a dosimeter film, or a plurality of such devices for a particular holder.
Referring to FIGURES 13, 14 and 19, halves of the single-site dosimeter holder are shown. The holder 10 (when assembled) is comprised of a first dosimeter block 12 (FIGURE 14) and a second dosimeter block 14 (FIGURE 13). The first block 12 comprises an interior surface 16 with a substantially square cavity 18 defined therein, and an outer surface 20 with a cylindrical passage 22 to the cavity 18 passing therethrough. The cavity 18 may be of any desired shape to accommodate a radiochromic film dosimeter, which typically comes as a small square piece-though other shapes and sizes may be more suitable for alternative embodiments. The embodiment of FIGURE 14 also illustrates four radiused corner notches 24 extending from the cavity 18. These notches 24 facilitate the removal of the radiochromic film dosimeter from the cavity 18. The passage 22 may also be machined to various shapes, if desired. In alternative embodiments, the passage 22 may be in the second dosimeter block 14 or pass through an adjacent side of the dosimeter block.
In the present embodiment, the second dosimeter block 14 of FIGURE 13 comprises an interior surface 26 with a protrusion 28 configured to abut an interior surface of the cavity 18 of block 12. In use, a radiochromic film dosimeter 30 is positioned within the cavity 18 of the first block 12 and held in place by the protrusion 28 of the second block 14.
A first mechanism (not shown), such as a pin, bolt, or similar device, is used to pass through aperture 79 to affix the first dosimeter block 12 to the second dosimeter block 14 to form a dosimeter holder or assembly 10 (FIGURE 19). Additionally, a second mechanism (not shown) may be used to affix the holder 10 to a radiation sterilization site, such as a component pallet. The first mechanism may perform the operation of the second mechanism for certain applications.
The material used for manufacturing the dosimeter holder 10 must be radiation resistant and be of sufficient density and thickness to shield the contained dosimeter 30 from indirect exposure to the electron beam. Overexposure of the dosimeter 30 is a concern as it will negatively affect validation and routine monitoring.
As a means for controlling exposure of the dosimeter 30, the size of the diameter and depth of the passage 22 may be adjusted. The larger the diameter of the passage 22 and the shorter the depth of the passage 22 (i.e., the thickness of the block material) the greater the dose the dosimeter 30 will receive. Conversely, the smaller the diameter and the longer the depth of the passage 22, the lower the dose received by the dosimeter 30. In a preferred embodiment, the passage depth is machined to 0.124 inch (3.15 mm) and the diameter is 0.234 inch (5.94 mm). The passage depth preferably falls within the range of from about 0.070 to about 0.175 inch (1.78 - 4.45 mm), while the preferred diameter is within the range of from about 0.175 to about 0.290 inch (4.45 - 7.37 mm). However, with varied applications and positioning of the assembly 10, as well as varied dosimeter thicknesses and surface areas, there exists an infinite combination of diameters and depths of the passage 22 which may be used without departing from the intended purpose of the present invention.
Referring now to FIGURES 5-8, an embodiment of a multi-site dosimeter holder 40a for the bag pallet may be more readily seen and understood. Like the single-site assembly, the multi-site holder is comprised of a first block 46 and a second block 48.
The illustrated embodiment is designed with four dosimeter sites 50 equally spaced along the length of the holder 40a. The number of dosimeter sites 50 may vary with the number of component sites 73 (see FIGURES 3 and 4) provided for in the component pallet 70, though an exact one-to-one correlation is not necessary. A greater number of dosimeter sites 50 per component sites 73 (e.g., 2:1, 4:1, etc.) may improve (or be necessary for) validation and routine monitoring.
In the present embodiment, the first block 46 of the multi-site holder 40a differs from that of the single-site holder 10 in other ways. A cavity 18 for containing a radiochromic film dosimeter 30 is present, but there is no passage to the cavity in the first block 46.
Rather, the second block 48, while comprising a protrusion 28 to fit within the cavity 18 of the first block 46 and retain the dosimeter therein, has a passage 22 through the protrusion 28. The function and the range of dimensions of the passage diameter and depth are otherwise identical to those of the,passage 22 in the single-site dosimeter holder 10. Of course, alternative embodiments may include the passage 22 on the first block 46 requiring only different positioning of the holder 40a on the pallet 70a.
As a means for controlling exposure of the dosimeter 30, the size of the diameter and depth of the passage 22 may be adjusted. The larger the diameter of the passage 22 and the shorter the depth of the passage 22 (i.e., the thickness of the block material) the greater the dose the dosimeter 30 will receive. Conversely, the smaller the diameter and the longer the depth of the passage 22, the lower the dose received by the dosimeter 30. In a preferred embodiment, the passage depth is machined to 0.124 inch (3.15 mm) and the diameter is 0.234 inch (5.94 mm). The passage depth preferably falls within the range of from about 0.070 to about 0.175 inch (1.78 - 4.45 mm), while the preferred diameter is within the range of from about 0.175 to about 0.290 inch (4.45 - 7.37 mm). However, with varied applications and positioning of the assembly 10, as well as varied dosimeter thicknesses and surface areas, there exists an infinite combination of diameters and depths of the passage 22 which may be used without departing from the intended purpose of the present invention.
Referring now to FIGURES 5-8, an embodiment of a multi-site dosimeter holder 40a for the bag pallet may be more readily seen and understood. Like the single-site assembly, the multi-site holder is comprised of a first block 46 and a second block 48.
The illustrated embodiment is designed with four dosimeter sites 50 equally spaced along the length of the holder 40a. The number of dosimeter sites 50 may vary with the number of component sites 73 (see FIGURES 3 and 4) provided for in the component pallet 70, though an exact one-to-one correlation is not necessary. A greater number of dosimeter sites 50 per component sites 73 (e.g., 2:1, 4:1, etc.) may improve (or be necessary for) validation and routine monitoring.
In the present embodiment, the first block 46 of the multi-site holder 40a differs from that of the single-site holder 10 in other ways. A cavity 18 for containing a radiochromic film dosimeter 30 is present, but there is no passage to the cavity in the first block 46.
Rather, the second block 48, while comprising a protrusion 28 to fit within the cavity 18 of the first block 46 and retain the dosimeter therein, has a passage 22 through the protrusion 28. The function and the range of dimensions of the passage diameter and depth are otherwise identical to those of the,passage 22 in the single-site dosimeter holder 10. Of course, alternative embodiments may include the passage 22 on the first block 46 requiring only different positioning of the holder 40a on the pallet 70a.
As shown in the cross-section of FIGURE 6, the first and second blocks, 46 and 48, are secured together to form a multi-site holder 40a. The holder 40a is then affixed to the bag pallet 70a, as illustrated in FIGURES 1-4. In the present embodiment, the holder 40a is affixed to the backside 72 of the pallet 70a. As explained in greater detail infra, each dosimeter site 50 of the holder 40a is positioned to correspond to a component site 73 (FIGURE 2) on the frontside 74 of the pallet 70a. Again, more than one dosimeter site may be used to correspond to a single component site, or vice versa. Similarly, more than one holder 40a may be employed on each pallet 70a-for example, one on the frontside and one on the backside of the pallet, or one for the first component and one for a second component held on the pallet.
Referring to FIGURES 15-18, another embodiment for a multi-site dosimeter holder, holder 40b is illustrated. This holder 40b has a 5:4 dosimeter site 50 to component site 73 ratio. While the holder 40b is shaped notably different than the bag pallet dosimeter holder 40a of FIGURES 5-8, the dosimeter sites 50 between the two embodiments are actually identically configured. The alternative embodiments disclosed for holder 40a also may be utilized for holder 40b.
FIGURES 9-12 illustrate the attachment of the holder 40b to the vial/device pallet 70b in a position which places the dosimeter sites 50 proximate the component sites 73.
Each component site 73 is sandwiched between two dosimeter sites 50 for improved validation.
Having discussed embodiments of the physical details of the present invention, the following is a detailed discussion of the validation process and a sterilization system in which the referenced holders as well as preferred operational parameters may be implemented.
One of the first steps in the validation process is to determine the sterilization dose to product required to achieve the desired SAL. One of two approaches is taken in selecting the sterilization dose: selection of sterilization dose using either bioburden information or information obtained by incremental dosing; or using a sterilization does of 25 kGy following substantiation of the appropriateness of the dose. Once established, the minimum radiation dose can be achieved in several ways known by those skilled in the art, including increasing the intensity (current) of the electron beam or by increasing the time that the product is in the electron beam field.
Referring to FIGURES 15-18, another embodiment for a multi-site dosimeter holder, holder 40b is illustrated. This holder 40b has a 5:4 dosimeter site 50 to component site 73 ratio. While the holder 40b is shaped notably different than the bag pallet dosimeter holder 40a of FIGURES 5-8, the dosimeter sites 50 between the two embodiments are actually identically configured. The alternative embodiments disclosed for holder 40a also may be utilized for holder 40b.
FIGURES 9-12 illustrate the attachment of the holder 40b to the vial/device pallet 70b in a position which places the dosimeter sites 50 proximate the component sites 73.
Each component site 73 is sandwiched between two dosimeter sites 50 for improved validation.
Having discussed embodiments of the physical details of the present invention, the following is a detailed discussion of the validation process and a sterilization system in which the referenced holders as well as preferred operational parameters may be implemented.
One of the first steps in the validation process is to determine the sterilization dose to product required to achieve the desired SAL. One of two approaches is taken in selecting the sterilization dose: selection of sterilization dose using either bioburden information or information obtained by incremental dosing; or using a sterilization does of 25 kGy following substantiation of the appropriateness of the dose. Once established, the minimum radiation dose can be achieved in several ways known by those skilled in the art, including increasing the intensity (current) of the electron beam or by increasing the time that the product is in the electron beam field.
The next step is to determine the dose distribution of the product being sterilized.
The dose distribution study or dose mapping is performed to identify the zones of minimum and maximum dose within the product(s) processed and to assess the reproducibility of the process. This information is then used to select the routine monitoring position for routine processing. That is, a location for the routine monitoring dosimeter must be determined such that during sterilization the level of radiation absorbed by the dosimeter (which is readily measurable) is proportional to that of the component to be sterilized (which is not readily measurable).
With a low energy electron beam, the correlation between the dose received by the product and the dose received by the dosimeter is difficult to achieve because of complex product geometries and the tendency of the dosimeter to be saturated in the direct path of the electron field. With the present invention, a correlation between the measured radiation exposure of the dosimeter and the desired dose to product can be made.
Referring to FIGURES 20-22, a preferred embodiment of the system for sterile connecting a plurality of components comprises a sterilization chamber 112 having a low-energy electron beam source 102, and a component pallet 70 capable of positioning at least two components within a sterilizing cloud created by the low-energy e-beam source within the sterilization chamber 112. A transportation source (not shown), such as a conveyor belt or indexing table, may be used to convey the component pallet 70 from a staging area to the sterilization chamber 112.
In the embodiment of FIGURE 20, the sterilization chamber 112 is preferably situated as a center compartment within a larger sterilization booth 110. The preferred sterilization system is comprised of two booths: a bag sterilization booth 110a (FIGURE 21) and a vial/device sterilization booth 11Ob (FIGURE 23). The two booths, 11 Oa and 110b, are identical in purpose, so the following discussion will merely refer to bag sterilization booth 110a. However, where key differences exist between the booths, such differences will be noted in this text and the appended drawing figures.
The two booths 110a and 110b are divided into three chambers: a pre-sterilization chamber 114, the sterilization chamber 112, and a post-sterilization chamber 116. Each chamber is comprised of a set of entrance doors and a set of exit doors. The exit doors 131 for the pre-sterilization chamber 114 also act as the entrance doors for the sterilization chamber 112. Likewise, the sterilization chamber exit doors 132 also function as the post-sterilization chamber 116 entrance doors. The doors are preferably laterally sliding doors actuated' by, for example, a hydraulic mechanism reacting to a sensor (not shown) and control system (not shown). As space allows, the doors may be designed to slide vertically or horizontally. A single panel or bi-parting panels may be used as well.
These added features and their implementation would be well-understood by those skilled in the relevant art of automated system design.
The four sets of chamber doors 130, 131, 132, and 133, are comprised of a one-inch lead core with a quarter-inch stainless steel exterior lining. Similarly, the chamber walls 134 are built to prevent accidental exposure of external personnel to radiation created by the electron beam source. Use of higher energy sources may require additional shielding. The sterilization chamber 112 should also be comprised of an appropriate ventilation means due to the creation of ozone from these energy sources.
As shown in FIGURES 21 and 22, the e-beam source is preferably provided by two oppositely positioned low-energy electron beam tubes 102. Presently, there only are a small number of suppliers for such tubes. Tube and beam dimension and output operating parameters are only a few factors which may guide selection. The preferred e-beam tubes for the present embodiment are approximately ten-inches in width and two-inches in height, and operate in the range of 60 to 125 KeV. Other suitable electron beam tubes may exist and those skilled in the art would understand what modification would be necessary to implement such tubes into the present system.
By training the resulting electron clouds of the opposing e-beam tubes 102 at the position of the pallet window 41 of either the bag pallet 70a or the vial/device pallet 70b, an electron "flood area" is created where connection of the components is contemplated.
Connection within the flood area insures that sterilization is maintained at every corner, crevice, and surface of the components. That is, shadowing caused by juxtapositioned surfaces is minimized, if not eliminated.
While the use of two electron beam sources is preferred for the present embodiment, it is contemplated that a single electron beam could be used in some applications. For example, the components could be rotated within the resulting electron cloud to effect sterilization, or the source beam could revolve about the components for the same effect.
Additionally, any number of electron beams may be used in an array fashion to further address shadowing of very complicated connections or oddly shaped components.
Referring now to FIGURE 20A-C, the movement of pallets 70 through the three chambered booth 110 can be more readily understood. Beginning with a completely empty booth 110, the door 130 into the pre-sterilization chamber 114 is opened. Here the first component pallet 70' is held until the door 130 is again closed. Then, after door 131 is opened and the first component pallet 70' enters the sterilization chamber 112, the door 131 is completely closed, and door 130 is opened to permit the entrance of a second component pallet 70", as shown in FIGURE 20A. At this time, the first component pallet 70' is subject to sterilization, the details of which will be explained in greater detail below. The door 130 is then closed as before, while door 132 is opened to allow the movement of the first component pallet 70' to the post-sterilization chamber 116. Simultaneously, door 131 is opened to allow the second component pallet 70" to enter the sterilization chamber 112, as shown in FIGURE 20B. Doors 131 and 132 are then closed. At this point, as shown in FIGURE 20C, the first component pallet 70' is in the post-sterilization chamber 116, acting as a holding chamber, and the second component pallet 70" is in the sterilization chamber 112.
Still referring to FIGURE 20C, doors 130 and 133 open to allow the movement of a third component pallet 70"' into the pre-sterilization chamber 114 and the first component pallet 70' out of the post-sterilization chamber 116. Doors 130 and 133 then close. The booth 110 would then contain second component pallet 70" in the sterilization chamber 112 and the third component pallet 70"' in the pre-sterilization chamber 114. The sequence is then repeated from the opening of doors 130 and 133 until all component pallets have passed through all three chambers of the booth 110. Following such a progression maintains a sealed door on either side of the electron source at all times, thereby providing a full-time barrier against the escape of stray radiation from the sterilization chamber.
Naturally, other sequences may be devised to achieve this important safety precaution.
Movement of the pallets is controlled by the three independent conveyor surfaces 120, 122, and 124. The first conveyor surface 120 is responsible for receiving a pallet from the system and transporting the pallet into the pre-sterilization chamber 114.
The first conveyor surface 120 and a second conveyor surface 122 work together to transport the pallet into the sterilization chamber 112. After sterilization, the second conveyor surface 122 and a third conveyor surface 124 cooperate to position the pallet within the post-sterilization chamber 116. Finally, the third conveyor surface 124 transports the pallet to the system for resumed handling. With alternate indexing through the chambers, variations on the number of conveyor surfaces used may be made. Those skilled in the art would understand how to correlate the indexing of pallets to the movement of the conveyor surfaces should variations be necessary.
Within the sterilization chamber 112, referring to FIGURES 21-23, the bag pallet 70a (FIGURE 21) or the vial/device pallet 70b (FIGURE 23) is positioned between the two electron beam sources 102. At this time, as shown in FIGURE 21, the shutters 136 are in a closed position. The shutters 136 are liquid cooled steel panels used to block the electron beam window before and after component sterilization and connection. As with.
the chamber doors, it is necessary that the shutters 136 be dense enough to provide proper shielding, so any cooling elements (which may require hollowing of the panel) are . preferably absent from a central portion of the shutter 136 where direct incidence of the electron beam is realized.
Referring to FIGURES 21 and 22, the shutters 136 are attached to a pneumatic actuator 140 which is responsive to a controller (not shown). A single controller may be used to control the chamber doors, 130, 131, 132, and 133, the conveyor surfaces 120, 122, and 124, and the shutters 136, if desired. After the chamber doors 131 and 132 are in a closed position (FIGURE 20A), the appropriate controller can activate pneumatic actuator 140 to raise shutters 136 (FIGURE 22). At this point, component exposure is controlled by the position of the components within the resulting electron cloud (preferably within the electron flood area) as well as the time of exposure (i.e., the time the shutters are raised).
Unlike the vial/device pallet 70b, the bag pallet 70a has additional heat shielding to protect the product of the components from electron beam exposure. Referring to FIGURES 21 and 22, a liquid-cooled, double-paneled heat shield 142 is initially positioned within the sterilization chamber 112. The lower portion 144 of the heat shield 142 is used to shield the bag component, and the upper portion 146 to shield the vial/device component 70b. As the bag holding portion of the bag pallet 70a is raised by actuator 140 to raise the bag component in the connecting step of the sterilization process, the lower portion 144 of the heat shield 142 moves simultaneously to maintain the shielding of the bag component.
Upon snap connection of the two components together, .the lower portion 144 abuts the upper portion 146 of the heat shield 142. The heat shield 142 is retracted (i.e., the lower portion 144 is returned to its starting position) only after the shutters 136 are closed and then simultaneously with the return of the actuated bag holding portion of the bag pallet 70a.
The dose distribution study or dose mapping is performed to identify the zones of minimum and maximum dose within the product(s) processed and to assess the reproducibility of the process. This information is then used to select the routine monitoring position for routine processing. That is, a location for the routine monitoring dosimeter must be determined such that during sterilization the level of radiation absorbed by the dosimeter (which is readily measurable) is proportional to that of the component to be sterilized (which is not readily measurable).
With a low energy electron beam, the correlation between the dose received by the product and the dose received by the dosimeter is difficult to achieve because of complex product geometries and the tendency of the dosimeter to be saturated in the direct path of the electron field. With the present invention, a correlation between the measured radiation exposure of the dosimeter and the desired dose to product can be made.
Referring to FIGURES 20-22, a preferred embodiment of the system for sterile connecting a plurality of components comprises a sterilization chamber 112 having a low-energy electron beam source 102, and a component pallet 70 capable of positioning at least two components within a sterilizing cloud created by the low-energy e-beam source within the sterilization chamber 112. A transportation source (not shown), such as a conveyor belt or indexing table, may be used to convey the component pallet 70 from a staging area to the sterilization chamber 112.
In the embodiment of FIGURE 20, the sterilization chamber 112 is preferably situated as a center compartment within a larger sterilization booth 110. The preferred sterilization system is comprised of two booths: a bag sterilization booth 110a (FIGURE 21) and a vial/device sterilization booth 11Ob (FIGURE 23). The two booths, 11 Oa and 110b, are identical in purpose, so the following discussion will merely refer to bag sterilization booth 110a. However, where key differences exist between the booths, such differences will be noted in this text and the appended drawing figures.
The two booths 110a and 110b are divided into three chambers: a pre-sterilization chamber 114, the sterilization chamber 112, and a post-sterilization chamber 116. Each chamber is comprised of a set of entrance doors and a set of exit doors. The exit doors 131 for the pre-sterilization chamber 114 also act as the entrance doors for the sterilization chamber 112. Likewise, the sterilization chamber exit doors 132 also function as the post-sterilization chamber 116 entrance doors. The doors are preferably laterally sliding doors actuated' by, for example, a hydraulic mechanism reacting to a sensor (not shown) and control system (not shown). As space allows, the doors may be designed to slide vertically or horizontally. A single panel or bi-parting panels may be used as well.
These added features and their implementation would be well-understood by those skilled in the relevant art of automated system design.
The four sets of chamber doors 130, 131, 132, and 133, are comprised of a one-inch lead core with a quarter-inch stainless steel exterior lining. Similarly, the chamber walls 134 are built to prevent accidental exposure of external personnel to radiation created by the electron beam source. Use of higher energy sources may require additional shielding. The sterilization chamber 112 should also be comprised of an appropriate ventilation means due to the creation of ozone from these energy sources.
As shown in FIGURES 21 and 22, the e-beam source is preferably provided by two oppositely positioned low-energy electron beam tubes 102. Presently, there only are a small number of suppliers for such tubes. Tube and beam dimension and output operating parameters are only a few factors which may guide selection. The preferred e-beam tubes for the present embodiment are approximately ten-inches in width and two-inches in height, and operate in the range of 60 to 125 KeV. Other suitable electron beam tubes may exist and those skilled in the art would understand what modification would be necessary to implement such tubes into the present system.
By training the resulting electron clouds of the opposing e-beam tubes 102 at the position of the pallet window 41 of either the bag pallet 70a or the vial/device pallet 70b, an electron "flood area" is created where connection of the components is contemplated.
Connection within the flood area insures that sterilization is maintained at every corner, crevice, and surface of the components. That is, shadowing caused by juxtapositioned surfaces is minimized, if not eliminated.
While the use of two electron beam sources is preferred for the present embodiment, it is contemplated that a single electron beam could be used in some applications. For example, the components could be rotated within the resulting electron cloud to effect sterilization, or the source beam could revolve about the components for the same effect.
Additionally, any number of electron beams may be used in an array fashion to further address shadowing of very complicated connections or oddly shaped components.
Referring now to FIGURE 20A-C, the movement of pallets 70 through the three chambered booth 110 can be more readily understood. Beginning with a completely empty booth 110, the door 130 into the pre-sterilization chamber 114 is opened. Here the first component pallet 70' is held until the door 130 is again closed. Then, after door 131 is opened and the first component pallet 70' enters the sterilization chamber 112, the door 131 is completely closed, and door 130 is opened to permit the entrance of a second component pallet 70", as shown in FIGURE 20A. At this time, the first component pallet 70' is subject to sterilization, the details of which will be explained in greater detail below. The door 130 is then closed as before, while door 132 is opened to allow the movement of the first component pallet 70' to the post-sterilization chamber 116. Simultaneously, door 131 is opened to allow the second component pallet 70" to enter the sterilization chamber 112, as shown in FIGURE 20B. Doors 131 and 132 are then closed. At this point, as shown in FIGURE 20C, the first component pallet 70' is in the post-sterilization chamber 116, acting as a holding chamber, and the second component pallet 70" is in the sterilization chamber 112.
Still referring to FIGURE 20C, doors 130 and 133 open to allow the movement of a third component pallet 70"' into the pre-sterilization chamber 114 and the first component pallet 70' out of the post-sterilization chamber 116. Doors 130 and 133 then close. The booth 110 would then contain second component pallet 70" in the sterilization chamber 112 and the third component pallet 70"' in the pre-sterilization chamber 114. The sequence is then repeated from the opening of doors 130 and 133 until all component pallets have passed through all three chambers of the booth 110. Following such a progression maintains a sealed door on either side of the electron source at all times, thereby providing a full-time barrier against the escape of stray radiation from the sterilization chamber.
Naturally, other sequences may be devised to achieve this important safety precaution.
Movement of the pallets is controlled by the three independent conveyor surfaces 120, 122, and 124. The first conveyor surface 120 is responsible for receiving a pallet from the system and transporting the pallet into the pre-sterilization chamber 114.
The first conveyor surface 120 and a second conveyor surface 122 work together to transport the pallet into the sterilization chamber 112. After sterilization, the second conveyor surface 122 and a third conveyor surface 124 cooperate to position the pallet within the post-sterilization chamber 116. Finally, the third conveyor surface 124 transports the pallet to the system for resumed handling. With alternate indexing through the chambers, variations on the number of conveyor surfaces used may be made. Those skilled in the art would understand how to correlate the indexing of pallets to the movement of the conveyor surfaces should variations be necessary.
Within the sterilization chamber 112, referring to FIGURES 21-23, the bag pallet 70a (FIGURE 21) or the vial/device pallet 70b (FIGURE 23) is positioned between the two electron beam sources 102. At this time, as shown in FIGURE 21, the shutters 136 are in a closed position. The shutters 136 are liquid cooled steel panels used to block the electron beam window before and after component sterilization and connection. As with.
the chamber doors, it is necessary that the shutters 136 be dense enough to provide proper shielding, so any cooling elements (which may require hollowing of the panel) are . preferably absent from a central portion of the shutter 136 where direct incidence of the electron beam is realized.
Referring to FIGURES 21 and 22, the shutters 136 are attached to a pneumatic actuator 140 which is responsive to a controller (not shown). A single controller may be used to control the chamber doors, 130, 131, 132, and 133, the conveyor surfaces 120, 122, and 124, and the shutters 136, if desired. After the chamber doors 131 and 132 are in a closed position (FIGURE 20A), the appropriate controller can activate pneumatic actuator 140 to raise shutters 136 (FIGURE 22). At this point, component exposure is controlled by the position of the components within the resulting electron cloud (preferably within the electron flood area) as well as the time of exposure (i.e., the time the shutters are raised).
Unlike the vial/device pallet 70b, the bag pallet 70a has additional heat shielding to protect the product of the components from electron beam exposure. Referring to FIGURES 21 and 22, a liquid-cooled, double-paneled heat shield 142 is initially positioned within the sterilization chamber 112. The lower portion 144 of the heat shield 142 is used to shield the bag component, and the upper portion 146 to shield the vial/device component 70b. As the bag holding portion of the bag pallet 70a is raised by actuator 140 to raise the bag component in the connecting step of the sterilization process, the lower portion 144 of the heat shield 142 moves simultaneously to maintain the shielding of the bag component.
Upon snap connection of the two components together, .the lower portion 144 abuts the upper portion 146 of the heat shield 142. The heat shield 142 is retracted (i.e., the lower portion 144 is returned to its starting position) only after the shutters 136 are closed and then simultaneously with the return of the actuated bag holding portion of the bag pallet 70a.
Referring to FIGURE 20C, the pallet 70 is then transferred to the post-sterilization chamber 116 for holding, as described above. From the post-sterilization chamber 116, the pallet 70 is capable of travel to other stations for further processing.
In a preferred embodiment, a pre-selected percentage of the sterilized pallets (e.g., 10%, 30%, 50%, etc.) may be routed to a verification station (not shown). At the verification station, the dosimeter holder, 40a and 40b, may be removed from the pallet, 70a and 70b, respectively. The holder may then be disassembled to gain access to the dosimeters 30. Of course, the dosimeters 30 should be handled with the necessary tools (e.g., tweezers) to prevent contamination.
After removal from the dosimeter holder 40, the absorbed radiation of each dosimeter 30 can be measured. If the measured radiation dose level is at or above the necessary level for achieving the required or desired SAL for each dosimeter, then the respective pallet may be validated as "sterile." The ability to validate the sterility of the components is a result of the correlated relationship determined to exist between the dosimeter film and the component on the pallet.
The pallet may re-enter the assembly process. The dosimeter holder 40 can now be fitted with new dosimeters and reattached to a suitable pallet 70 to repeat the process.
While the invention has been shown and described with reference to the preferred embodiments, it will be understood by those skilled in the art that various changes in form and detail may be made therein without departing from the spirit and scope of the invention as defined by the appended claims.
In a preferred embodiment, a pre-selected percentage of the sterilized pallets (e.g., 10%, 30%, 50%, etc.) may be routed to a verification station (not shown). At the verification station, the dosimeter holder, 40a and 40b, may be removed from the pallet, 70a and 70b, respectively. The holder may then be disassembled to gain access to the dosimeters 30. Of course, the dosimeters 30 should be handled with the necessary tools (e.g., tweezers) to prevent contamination.
After removal from the dosimeter holder 40, the absorbed radiation of each dosimeter 30 can be measured. If the measured radiation dose level is at or above the necessary level for achieving the required or desired SAL for each dosimeter, then the respective pallet may be validated as "sterile." The ability to validate the sterility of the components is a result of the correlated relationship determined to exist between the dosimeter film and the component on the pallet.
The pallet may re-enter the assembly process. The dosimeter holder 40 can now be fitted with new dosimeters and reattached to a suitable pallet 70 to repeat the process.
While the invention has been shown and described with reference to the preferred embodiments, it will be understood by those skilled in the art that various changes in form and detail may be made therein without departing from the spirit and scope of the invention as defined by the appended claims.
Claims (11)
1. A method for verifying sterilization of components in a sterilization system using a low-energy electron beam comprising the steps of:
determining a minimum sterilization dose which when applied to a sample of a component results in a desired sterility assurance level (SAL) of less than about 10-3;
exposing a sample component and a plurality of indicators to the low-energy electron beam;
measuring a sterilization dose received at each indicator, at least one of the plurality of indicators providing a sterilization dose measurement indicative of the sterilization dose at the sample component;
determining a dose distribution of the sample component;
establishing a correlation between the sterilization dose at the sample component and the sterilization dose measured at at least one of the plurality of indicators;
placing a component to be sterilized onto a component pallet;
attaching by a mechanism a holder containing a correlated indicator therein to the component pallet as a site to be used to indicate achievement of at least the minimum sterilization dose;
exposing the component and correlated indicator to the low-energy electron beam;
determining the sterilization dose at the indicator; and ascertaining the efficacy of the sterilization dose achieved at the component based on the determined sterilization dose at the correlated indicator.
determining a minimum sterilization dose which when applied to a sample of a component results in a desired sterility assurance level (SAL) of less than about 10-3;
exposing a sample component and a plurality of indicators to the low-energy electron beam;
measuring a sterilization dose received at each indicator, at least one of the plurality of indicators providing a sterilization dose measurement indicative of the sterilization dose at the sample component;
determining a dose distribution of the sample component;
establishing a correlation between the sterilization dose at the sample component and the sterilization dose measured at at least one of the plurality of indicators;
placing a component to be sterilized onto a component pallet;
attaching by a mechanism a holder containing a correlated indicator therein to the component pallet as a site to be used to indicate achievement of at least the minimum sterilization dose;
exposing the component and correlated indicator to the low-energy electron beam;
determining the sterilization dose at the indicator; and ascertaining the efficacy of the sterilization dose achieved at the component based on the determined sterilization dose at the correlated indicator.
2. The method of Claim 1, wherein the step of determining the level of the sterilization dose at the correlated indicator is achieved by a sensor.
3. The method of Claim 2, wherein the sensor is a radiation dosimeter.
4. The method of Claim 1, wherein the correlated indicator comprises a dosimeter.
5. The method of Claim 1, wherein the indicator comprises a plurality of dosimeters.
6. The method of Claim 5, wherein the dosimeters are detachably affixed to the pallet.
7. The method of Claim 1, wherein the correlated indicator is detachably affixed to the pallet.
8. The method of Claim 1, wherein the holder is attached to the pallet by one of a pin and a bolt.
9. A system for verifying the sterility of components comprising:
a sterilization chamber;
a pallet member configured to position a component within the sterilization chamber;
a dosimeter holder having a plurality of dosimeters contained therein, the dosimeter holder detachably affixed to the pallet member by a mechanism and including a plurality of passages permitting radiation to reach the plurality of contained dosimeters;
a low-energy sterilization source configured to deliver a sterilization dose to a component and a correlated dose to the dosimeter within the sterilization chamber, wherein the sterilization dose results in a desired sterility assurance level ("SAL") of less than about
a sterilization chamber;
a pallet member configured to position a component within the sterilization chamber;
a dosimeter holder having a plurality of dosimeters contained therein, the dosimeter holder detachably affixed to the pallet member by a mechanism and including a plurality of passages permitting radiation to reach the plurality of contained dosimeters;
a low-energy sterilization source configured to deliver a sterilization dose to a component and a correlated dose to the dosimeter within the sterilization chamber, wherein the sterilization dose results in a desired sterility assurance level ("SAL") of less than about
10-3;
a verification station located apart from the sterilization chamber at which the dosimeter holder is removed from the pallet member and the dosimeter holder is disassembled to gain access to the plurality of dosimeters for measuring the correlated dose absorbed by the plurality of dosimeters within the sterilization chamber; and wherein the sterilization chamber, the pallet member, the dosimeter holder, the low energy sterilization source, and the verification station are configured and arranged to enable the correlated dose to be determined by (i) exposing a sample component and the plurality of dosimeters to the low-energy sterilization source, (ii) measuring a sterilization dose received at each dosimeter, at least one of the plurality of dosimeters providing a sterilization dose measurement indicative of the sterilization dose at the sample component, (iii) determining a dose distribution of the sample component, and (iv) establishing a correlation between the sterilization dose at the sample component and the sterilization dose measured at the at least one of the plurality of dosimeters.
10. The system of Claim 9, further comprising at least two components positioned on the pallet member and an actuator which drives at least one of the components while in the sterilization chamber to effect connection between the components.
a verification station located apart from the sterilization chamber at which the dosimeter holder is removed from the pallet member and the dosimeter holder is disassembled to gain access to the plurality of dosimeters for measuring the correlated dose absorbed by the plurality of dosimeters within the sterilization chamber; and wherein the sterilization chamber, the pallet member, the dosimeter holder, the low energy sterilization source, and the verification station are configured and arranged to enable the correlated dose to be determined by (i) exposing a sample component and the plurality of dosimeters to the low-energy sterilization source, (ii) measuring a sterilization dose received at each dosimeter, at least one of the plurality of dosimeters providing a sterilization dose measurement indicative of the sterilization dose at the sample component, (iii) determining a dose distribution of the sample component, and (iv) establishing a correlation between the sterilization dose at the sample component and the sterilization dose measured at the at least one of the plurality of dosimeters.
10. The system of Claim 9, further comprising at least two components positioned on the pallet member and an actuator which drives at least one of the components while in the sterilization chamber to effect connection between the components.
11. The system of Claim 10, wherein the dosimeter holder is detachably affixed to the pallet by one of a pin and a bolt.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/745,466 US7641851B2 (en) | 2003-12-23 | 2003-12-23 | Method and apparatus for validation of sterilization process |
US10/745,466 | 2003-12-23 | ||
PCT/US2004/040146 WO2005065728A1 (en) | 2003-12-23 | 2004-12-01 | Method and apparatus for validation of sterilization process |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2546846A1 CA2546846A1 (en) | 2005-07-21 |
CA2546846C true CA2546846C (en) | 2012-08-28 |
Family
ID=34679165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2546846A Expired - Fee Related CA2546846C (en) | 2003-12-23 | 2004-12-01 | Method and apparatus for validation of sterilization process |
Country Status (11)
Country | Link |
---|---|
US (2) | US7641851B2 (en) |
EP (2) | EP1708759B1 (en) |
JP (1) | JP2007516774A (en) |
CN (1) | CN100556462C (en) |
AT (1) | ATE554794T1 (en) |
AU (2) | AU2004311924B2 (en) |
CA (1) | CA2546846C (en) |
ES (2) | ES2386894T3 (en) |
MX (1) | MXPA06006475A (en) |
PL (1) | PL1708759T3 (en) |
WO (1) | WO2005065728A1 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8114342B2 (en) * | 2006-03-31 | 2012-02-14 | The Invention Science Fund I, Llc | Methods and systems for monitoring sterilization status |
US7638090B2 (en) * | 2006-03-31 | 2009-12-29 | Searete Llc | Surveying sterilizer methods and systems |
US20070231192A1 (en) * | 2006-03-31 | 2007-10-04 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Sterilization methods and systems |
US8758679B2 (en) | 2006-03-31 | 2014-06-24 | The Invention Science Fund I, Llc | Surveying sterilizer methods and systems |
US8932535B2 (en) | 2006-03-31 | 2015-01-13 | The Invention Science Fund I, Llc | Surveying sterilizer methods and systems |
US20090232703A1 (en) | 2006-03-31 | 2009-09-17 | Searete Llc | Methods and systems for monitoring sterilization status |
US8277724B2 (en) * | 2006-03-31 | 2012-10-02 | The Invention Science Fund I, Llc | Sterilization methods and systems |
US20070254015A1 (en) * | 2006-04-28 | 2007-11-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Sanitizing surfaces |
US7704453B2 (en) * | 2007-06-07 | 2010-04-27 | Ethicon, Inc. | Method for establishing a sterilizing dose for radiation sensitive products |
WO2009009683A1 (en) * | 2007-07-11 | 2009-01-15 | Stokely-Van Camp, Inc. | Active sterilization zone for container filling |
ES2546087T3 (en) * | 2008-04-10 | 2015-09-18 | Abbott Diabetes Care Inc. | Procedure and system to sterilize an analyte detector |
DE102008045187A1 (en) * | 2008-08-30 | 2010-03-04 | Krones Ag | Electron beam sterilization for containers |
US20100148065A1 (en) * | 2008-12-17 | 2010-06-17 | Baxter International Inc. | Electron beam sterilization monitoring system and method |
KR101014286B1 (en) * | 2009-01-12 | 2011-02-16 | 주식회사 메디파마플랜 | A sealing and filling system of medical solution bag |
MX2011011675A (en) * | 2009-05-05 | 2012-02-28 | Sidel Spa Con Socio Unico | A unit and a method for sterilizing container closures. |
US8795439B2 (en) * | 2009-07-21 | 2014-08-05 | Beasley Ip Holdings, Llc | Method and apparatus for washing temporary road mats |
JP5791459B2 (en) * | 2011-10-17 | 2015-10-07 | 日立造船株式会社 | Shielding structure for electron beam sterilization equipment |
DE102011056628A1 (en) | 2011-12-19 | 2013-06-20 | Krones Aktiengesellschaft | Device and method for sterilizing containers with function monitoring |
EP2836242A4 (en) * | 2012-04-12 | 2015-12-16 | Electronworks Holdings Llc | Low energy electron sterilization |
WO2014087247A2 (en) | 2012-12-05 | 2014-06-12 | Bracco Imaging S.P.A. | Validation techniques for fluid delivery systems |
US10647461B2 (en) | 2017-05-23 | 2020-05-12 | Biosense Webster (Israel) Ltd. | Methods and apparatus for cleansing and packaging medical instruments or the like |
US11786620B2 (en) | 2018-04-30 | 2023-10-17 | CathBuddy, Inc. | Handheld cleaner-disinfector for medical devices |
US10639389B2 (en) * | 2018-04-30 | 2020-05-05 | CathBuddy, Inc | Methods and devices for portable sterilization and containment of medical devices |
WO2020104280A1 (en) * | 2018-11-23 | 2020-05-28 | Tetra Laval Holdings & Finance S.A. | Measuring tool for irradiation source and method for measuring radiation |
US11603551B2 (en) | 2020-12-02 | 2023-03-14 | Steritec Products Mfg. Co., Inc. | Biological indicators, and systems and methods for determining efficacy of sterilization |
Family Cites Families (439)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1766151U (en) | 1957-06-25 | 1958-05-08 | Lorenz C Ag | BASS RESONANCE ENCLOSURE WITH DAMPING. |
FR2102622A6 (en) | 1970-08-12 | 1972-04-07 | Goupil Jean Jacques | |
DE1913926U (en) | 1963-01-24 | 1965-04-15 | Eitel Bode Armaturen Und Vertr | BALL SEAL WITH A DISC SPRING-LOADED SEALING ELEMENT. |
US3336924A (en) | 1964-02-20 | 1967-08-22 | Sarnoff | Two compartment syringe package |
US3330281A (en) | 1964-08-21 | 1967-07-11 | Upjohn Co | Combination syringe and vial mixing container |
US3330282A (en) | 1964-08-21 | 1967-07-11 | Upjohn Co | Combination syringe and vial mixing container |
FR1528920A (en) | 1967-05-05 | 1968-06-14 | Multi-capacity cartridge for conditioning pre-dosed substances | |
FR2061819A5 (en) | 1969-05-02 | 1971-06-25 | Goupil Jean Jacques | |
US3552387A (en) | 1968-07-16 | 1971-01-05 | Peter A Stevens | Combination syringe and vial |
US3788369A (en) | 1971-06-02 | 1974-01-29 | Upjohn Co | Apparatus for transferring liquid between a container and a flexible bag |
US3923059A (en) | 1971-07-01 | 1975-12-02 | Ims Ltd | Medicament injector |
US3826261A (en) | 1971-12-27 | 1974-07-30 | Upjohn Co | Vial and syringe assembly |
FR2188565A5 (en) | 1972-06-13 | 1974-01-18 | Semco Emballage Conditio | |
US4170994A (en) | 1974-09-26 | 1979-10-16 | Otsuka Pharmaceutical Factory, Inc. | Plastic containers for parenteral solutions |
US4014330A (en) | 1975-10-28 | 1977-03-29 | Abbott Laboratories | Disposable two-compartment syringe |
US4031895A (en) | 1976-04-05 | 1977-06-28 | Porter Robert E | Syringe assembly package |
US4226330A (en) | 1976-11-01 | 1980-10-07 | Butler Robert W | Rupture lines in flexible packages |
US4059112A (en) | 1976-11-19 | 1977-11-22 | Tischlinger Edward A | Disposable additive syringe |
US4210173A (en) | 1976-12-06 | 1980-07-01 | American Hospital Supply Corporation | Syringe pumping system with valves |
US4116196A (en) | 1977-03-17 | 1978-09-26 | Survival Technology, Inc. | Additive adapter |
US4270533A (en) | 1977-08-16 | 1981-06-02 | Andreas Joseph M | Multiple chamber container for delivering liquid under pressure |
US4172457A (en) | 1977-10-06 | 1979-10-30 | American Hospital Supply Corporation | Plural component mixing system and method |
DE7732670U1 (en) | 1977-10-22 | 1978-02-16 | Buender Glas Gmbh, 4980 Buende | TWO-CHAMBER SYRINGE IN THE FORM OF AN INJECTION SYRINGE |
US4303071A (en) | 1978-08-07 | 1981-12-01 | Baxa Corporation | Syringe-type liquid container dispenser adapter |
DE2929425A1 (en) | 1979-07-20 | 1981-02-12 | Lothar Kling | DEVICE FOR INJECTION SYRINGES FOR INTRAMUSCULAR AND SUBENTANE INJECTION |
US4346511A (en) | 1979-07-05 | 1982-08-31 | The United States Of America As Represented By The United States Department Of Energy | Method for preparing dosimeter for measuring skin dose |
US4247651A (en) | 1979-09-12 | 1981-01-27 | Otsuka Kagaku Yakuhin Kabushiki Kaisha | Process for preparing foamed synthetic resin products |
SE8002709L (en) | 1980-04-10 | 1981-10-11 | Vitrum Ab | pACKING |
US4328802A (en) | 1980-05-14 | 1982-05-11 | Survival Technology, Inc. | Wet dry syringe package |
WO1982003208A1 (en) | 1981-03-18 | 1982-09-30 | John Maloney | Bag and bag making apparatus |
US4465488A (en) | 1981-03-23 | 1984-08-14 | Baxter Travenol Laboratories, Inc. | Collapsible multi-chamber medical fluid container |
US4432788A (en) | 1981-04-23 | 1984-02-21 | Nippon Kokan Kabushiki Kaisha | Method for manufacturing non-fired iron-bearing pellet |
JPS598222Y2 (en) * | 1981-06-11 | 1984-03-13 | 動力炉・核燃料開発事業団 | General-purpose personal dosimeter |
US5069671A (en) | 1981-07-13 | 1991-12-03 | Alza Corporation | Intravenous medication |
US4511353A (en) | 1981-07-13 | 1985-04-16 | Alza Corporation | Intravenous system for delivering a beneficial agent |
USRE34365E (en) | 1981-07-13 | 1993-08-31 | Intravenous system for delivering a beneficial agent | |
US4552555A (en) | 1981-07-31 | 1985-11-12 | Alza Corporation | System for intravenous delivery of a beneficial agent |
US4790820A (en) | 1981-07-13 | 1988-12-13 | Alza Corporation | Parenteral agent dispensing equipment with drug releasing member |
US4857052A (en) | 1981-07-13 | 1989-08-15 | Alza Corporation | Intravenous system for delivering a beneficial agent |
US4432756A (en) | 1981-11-27 | 1984-02-21 | Alza Corporation | Parenteral controlled therapy |
US4994031A (en) * | 1981-07-13 | 1991-02-19 | Alza Corporation | Intravenous system for delivering a beneficial agent |
US4973307A (en) | 1981-07-13 | 1990-11-27 | Alza Corporation | Method for administering drugs to a patient |
US4740201A (en) | 1981-10-09 | 1988-04-26 | Alza Corporation | Intravenous system for delivering a beneficial agent |
US4740198A (en) | 1981-10-09 | 1988-04-26 | Alza Corporation | Method of administering intravenous drug using rate-controlled dosage form |
US4525162A (en) | 1981-07-31 | 1985-06-25 | Alza Corporation | Parenteral controlled delivery |
US4871360A (en) | 1981-07-31 | 1989-10-03 | Alza Corporation | System for intravenous delivery of a beneficial drug at a regulated rates |
GB2104044B (en) * | 1981-08-07 | 1985-08-21 | Craig Med Prod Ltd | Bag and valve assembley for medical use |
US4465471A (en) | 1981-08-26 | 1984-08-14 | Eli Lilly And Company | Intravenous administration system for dry medicine |
US4740103A (en) | 1981-10-09 | 1988-04-26 | Alza Corporation | Intravenous system for delivering a beneficial agent |
US4586922A (en) | 1981-10-09 | 1986-05-06 | Alza Corporation | Intravenous system for delivering a beneficial agent |
US4521211A (en) | 1981-10-09 | 1985-06-04 | Alza Corporation | Parenteral agent dispensing equipment |
US4740197A (en) | 1981-10-09 | 1988-04-26 | Alza Corporation | Intravenous system for delivering a beneficial agent via polymer delivery |
US4740199A (en) | 1981-10-09 | 1988-04-26 | Alza Corporation | Intravenous system for delivering a beneficial agent |
US4548598A (en) | 1981-10-09 | 1985-10-22 | Alza Corporation | Parenteral agent dispensing equipment |
US4439183A (en) * | 1981-10-09 | 1984-03-27 | Alza Corporation | Parenteral agent dispensing equipment |
US4741734A (en) | 1981-10-09 | 1988-05-03 | Alza Corporation | Releasing means for adding agent using releasing means to IV fluid |
US4741735A (en) | 1981-10-09 | 1988-05-03 | Alza Corporation | Intravenous system for delivering a beneficial agent |
US4740200A (en) | 1981-10-09 | 1988-04-26 | Alza Corporation | Intravenous system for delivering a beneficial agent |
US4396383A (en) | 1981-11-09 | 1983-08-02 | Baxter Travenol Laboratories, Inc. | Multiple chamber solution container including positive test for homogenous mixture |
US4392850A (en) | 1981-11-23 | 1983-07-12 | Abbott Laboratories | In-line transfer unit |
US4392851A (en) | 1981-11-23 | 1983-07-12 | Abbott Laboratories | In-line transfer unit |
US4579553A (en) | 1981-11-27 | 1986-04-01 | Alza Corporation | Parenteral controlled therapy |
US4424056A (en) | 1981-11-27 | 1984-01-03 | Alza Corporation | Parenteral administration |
US4484909A (en) | 1981-11-27 | 1984-11-27 | Alza Corporation | Parenteral therapy using solid drug |
US4548599A (en) | 1981-11-27 | 1985-10-22 | Alza Corporation | Parenteral controlled therapy |
US4479793A (en) | 1981-11-27 | 1984-10-30 | Alza Corporation | Parenteral administration using drug delivery device |
US4552556A (en) | 1981-11-27 | 1985-11-12 | Alza Corporation | Parenteral controlled therapy |
US4583981A (en) | 1981-11-27 | 1986-04-22 | Alza Corporation | Parenteral controlled therapy, using a porous matrix with parenteral agent |
US4479794A (en) | 1981-11-27 | 1984-10-30 | Alza Corporation | System for intravenous therapy |
US4516967A (en) | 1981-12-21 | 1985-05-14 | Kopfer Rudolph J | Wet-dry compartmental syringe |
EP0083778B1 (en) | 1982-01-07 | 1987-11-11 | Fresenius AG | Preservation bag |
US4474574A (en) | 1982-01-11 | 1984-10-02 | Alza Corporation | Formulation dispenser for use with a parenteral delivery system |
US4439182A (en) | 1982-03-15 | 1984-03-27 | Huang Shing S J | Valvular infusion device |
US4493703A (en) | 1982-03-31 | 1985-01-15 | Butterfield Group | Hypodermic syringe cartridge with non-retractable drive piston |
US4424057A (en) | 1982-04-01 | 1984-01-03 | House Hugh A | Wet-dry syringe |
US4484920A (en) | 1982-04-06 | 1984-11-27 | Baxter Travenol Laboratories, Inc. | Container for mixing a liquid and a solid |
US4467588A (en) | 1982-04-06 | 1984-08-28 | Baxter Travenol Laboratories, Inc. | Separated packaging and sterile processing for liquid-powder mixing |
US4410321A (en) | 1982-04-06 | 1983-10-18 | Baxter Travenol Laboratories, Inc. | Closed drug delivery system |
US4458733A (en) | 1982-04-06 | 1984-07-10 | Baxter Travenol Laboratories, Inc. | Mixing apparatus |
NL8320092A (en) | 1982-04-07 | 1984-03-01 | Sony Corp | FOR LIGHT-SENSITIVE IMAGING MATERIAL. |
US4664650A (en) | 1982-05-24 | 1987-05-12 | Alza Corporation | Apparatus for parenteral infusion of fluid containing beneficial agent |
US4908019A (en) * | 1982-05-24 | 1990-03-13 | Alza Corporation | Apparatus comprising dual reservoirs for parenteral infusion of fluid containing beneficial agent |
US4432754A (en) | 1982-05-24 | 1984-02-21 | Alza Corporation | Apparatus for parenteral infusion of fluid containing beneficial agent |
US4515585A (en) | 1982-05-24 | 1985-05-07 | Alza Corporation | System for parenteral administration of agent |
US4534757A (en) | 1982-06-14 | 1985-08-13 | Alza Corporation | Device for releasing active ingredient, insertable in a system of parenteral administering the ingredient |
US4469872A (en) | 1982-08-20 | 1984-09-04 | Zoecon Corporation | Substituted pyridyloxyphenoxyhydroxyketones |
EP0107873B1 (en) | 1982-10-27 | 1987-06-24 | Duphar International Research B.V | Hypodermic syringe having a telescopic assembly between cartridge and medicament holder |
US4507113A (en) | 1982-11-22 | 1985-03-26 | Derata Corporation | Hypodermic jet injector |
US5199947A (en) | 1983-01-24 | 1993-04-06 | Icu Medical, Inc. | Method of locking an influent line to a piggyback connector |
US5344414A (en) | 1983-01-24 | 1994-09-06 | Icu Medical Inc. | Medical connector |
US5281206A (en) * | 1983-01-24 | 1994-01-25 | Icu Medical, Inc. | Needle connector with rotatable collar |
US5330450A (en) | 1983-01-24 | 1994-07-19 | Icu Medical, Inc. | Medical connector |
US5688254A (en) | 1983-01-24 | 1997-11-18 | Icu Medical, Inc. | Medical connector |
US4752292A (en) | 1983-01-24 | 1988-06-21 | Icu Medical, Inc. | Medical connector |
US4996579A (en) * | 1983-02-04 | 1991-02-26 | The United States Of America As Represented By The Secretary Of The Navy | Design for electronic spectrally tunable infrared detector |
DE3305365C2 (en) | 1983-02-17 | 1989-06-29 | Fresenius AG, 6380 Bad Homburg | Storage bag |
US4505709A (en) | 1983-02-22 | 1985-03-19 | Froning Edward C | Liquid transfer device |
US4614267A (en) | 1983-02-28 | 1986-09-30 | Abbott Laboratories | Dual compartmented container |
SE434700B (en) | 1983-05-20 | 1984-08-13 | Bengt Gustavsson | DEVICE FOR AIRED TRANSFER OF SUBSTANCE FROM A KERLE TO ANOTHER |
AU575814B2 (en) | 1983-03-03 | 1988-08-11 | Bengt Gustavsson | A device for transferring a substance |
US4623334A (en) | 1983-03-07 | 1986-11-18 | Vanderbilt University | Intravenous drug infusion apparatus |
US4820269A (en) | 1983-03-07 | 1989-04-11 | Vanderbilt University | Mixer apparatus for controlling intravenous drug infusion |
US4458811A (en) | 1983-04-21 | 1984-07-10 | Abbott Laboratories | Compartmented flexible solution container |
EP0122968B1 (en) | 1983-04-25 | 1987-08-19 | S.C. Johnson & Son, Inc. | Method for forming a burstable pouch |
US4808381A (en) * | 1983-05-13 | 1989-02-28 | E. I. Du Pont De Nemours And Company | Fluid transfer device |
US4534758A (en) | 1983-07-15 | 1985-08-13 | Eli Lilly & Company | Controlled release infusion system |
US4550825A (en) | 1983-07-27 | 1985-11-05 | The West Company | Multicompartment medicament container |
US4533348A (en) | 1983-07-29 | 1985-08-06 | Alza Corporation | In-line drug dispenser for use in intravenous therapy |
US4518386A (en) | 1983-08-31 | 1985-05-21 | Tartaglia John A | Medicine container having lyophilized powder and diluent stored in separate sealed chambers |
US4538918A (en) | 1983-09-19 | 1985-09-03 | Trimedyne, Inc. | Medication mixing and sequential administration device |
US4548606A (en) | 1983-09-29 | 1985-10-22 | Abbott Laboratories | Dual compartmented container with activating means |
US4573993A (en) | 1983-09-29 | 1986-03-04 | Instafil, Inc. | Fluid transfer apparatus |
US4568331A (en) | 1983-10-17 | 1986-02-04 | Marcus Fischer | Disposable medicine dispensing device |
US4507114A (en) | 1983-10-21 | 1985-03-26 | Baxter Travenol Laboratories, Inc. | Multiple chamber container having leak detection compartment |
US4601704A (en) | 1983-10-27 | 1986-07-22 | Abbott Laboratories | Container mixing system with externally mounted drug container |
US4589879A (en) | 1983-11-04 | 1986-05-20 | Baxter Travenol Laboratories, Inc. | Cannula assembly having closed, pressure-removable piercing tip |
US4573967A (en) | 1983-12-06 | 1986-03-04 | Eli Lilly And Company | Vacuum vial infusion system |
JPS60135446A (en) | 1983-12-22 | 1985-07-18 | Otsuka Chem Co Ltd | Melt-moldable fluororesin composition |
US4583971A (en) | 1984-02-10 | 1986-04-22 | Travenol European Research And Development Centre (Teradec) | Closed drug delivery system |
US4606734A (en) | 1984-02-22 | 1986-08-19 | Abbott Laboratories | Container mixing system with externally mounted drug container |
IT1173370B (en) | 1984-02-24 | 1987-06-24 | Erba Farmitalia | SAFETY DEVICE TO CONNECT A SYRINGE TO THE MOUTH OF A BOTTLE CONTAINING A DRUG OR A TUBE FOR DISPENSING THE SYRINGE DRUG |
US4602910A (en) | 1984-02-28 | 1986-07-29 | Larkin Mark E | Compartmented flexible solution container |
US4581016A (en) | 1984-02-29 | 1986-04-08 | Gettig Pharmaceutical Instrument Co. | Dual cartridge wet/dry syringe |
US4543094A (en) | 1984-03-19 | 1985-09-24 | Barnwell John K | Syringe and accessory |
IE57676B1 (en) | 1984-03-19 | 1993-02-24 | Abbott Lab | Drug delivery system |
US4543101A (en) | 1984-03-28 | 1985-09-24 | Adria Laboratories, Inc. | Valve device to aid in reconstituting injectable powders |
IT1214872B (en) | 1984-04-06 | 1990-01-18 | Mariano Feriani | BAG CONTAINING TWO OR MORE SUBSTANCES FOR INFUSION FOR MEDICAL USE, PLACED IN SEPARATE COMPARTMENTS, INCLUDING MEANS SUITABLE TO ALLOW THE MIXING OF SUCH SUBSTANCES ONLY AT THE TIME OF USE. |
US4711359A (en) | 1984-04-12 | 1987-12-08 | Baxter Travenol Laboratories, Inc. | Container such as a nursing container, having protection compartment for dispensing member |
US4637934A (en) * | 1984-04-12 | 1987-01-20 | Baxter Travenol Laboratories, Inc. | Liquid container with integral opening apparatus |
US5088996A (en) * | 1984-04-16 | 1992-02-18 | Kopfer Rudolph J | Anti-aerosoling drug reconstitution device |
US4568336A (en) | 1984-04-26 | 1986-02-04 | Microbiological Applications, Inc. | Pre-filled hypodermic syringes |
US4596555A (en) | 1984-05-14 | 1986-06-24 | Alza Corporation | Parenteral delivery system utilizing a hollow fiber cellular unit |
US4511352A (en) | 1984-05-14 | 1985-04-16 | Alza Corporation | Parenteral delivery system with in-line container |
US4511351A (en) | 1984-05-14 | 1985-04-16 | Alza Corporation | Parenteral delivery system utilizing a hollow fiber cellular unit |
US4906103A (en) * | 1984-05-30 | 1990-03-06 | Ti Kao | Devices and methods for preparing a solution for medicinal purposes |
US4552277A (en) | 1984-06-04 | 1985-11-12 | Richardson Robert D | Protective shield device for use with medicine vial and the like |
US4915689A (en) | 1984-06-13 | 1990-04-10 | Alza Corporation | Parenteral delivery system comprising a vial containing a beneficial agent |
US4519499A (en) | 1984-06-15 | 1985-05-28 | Baxter Travenol Laboratories, Inc. | Container having a selectively openable seal line and peelable barrier means |
US4608043A (en) | 1984-06-22 | 1986-08-26 | Abbott Laboratories | I.V. fluid storage and mixing system |
US4610684A (en) | 1984-06-22 | 1986-09-09 | Abbott Laboratories | Flexible container and mixing system for storing and preparing I.V. fluids |
US4540403A (en) | 1984-07-02 | 1985-09-10 | Alza Corporation | Parenteral dispensing system with programmable drug administration |
US4692144A (en) | 1984-08-20 | 1987-09-08 | Alza Corporation | System for providing intravenously administrable drug formulation |
US4607671A (en) | 1984-08-21 | 1986-08-26 | Baxter Travenol Laboratories, Inc. | Reconstitution device |
US4723956A (en) * | 1984-09-14 | 1988-02-09 | Baxter Travenol Laboratories, Inc. | Port free container |
US4759756A (en) | 1984-09-14 | 1988-07-26 | Baxter Travenol Laboratories, Inc. | Reconstitution device |
US4695272A (en) | 1984-10-26 | 1987-09-22 | Aktiebolaget Hassle | Drug release device |
US4668219A (en) | 1984-11-16 | 1987-05-26 | Israel Michael B | Exponential mixing and delivery system |
US4589867A (en) | 1984-11-16 | 1986-05-20 | Israel Michael B | Exponential mixing and delivery system |
AU592546B2 (en) | 1984-12-03 | 1990-01-18 | Baxter International Inc. | Drug delivery apparatus preventing local and systemic toxicity |
US4874366A (en) | 1984-12-03 | 1989-10-17 | Baxter Internatiional Inc. | Housing enabling passive mixing of a beneficial agent with a diluent |
US4652763A (en) * | 1985-03-29 | 1987-03-24 | Energy Sciences, Inc. | Electron-beam irradiation sterilization process |
US4704535A (en) * | 1985-04-11 | 1987-11-03 | Teledyne Industries, Inc. | Ultraviolet dosimetry |
DE3686764T2 (en) | 1985-06-14 | 1993-02-11 | Shinsozai Sogo Kenkyusho Kk | MEDICAL LIQUID CONTAINER AND THEIR PRODUCTION. |
US4613326A (en) | 1985-07-12 | 1986-09-23 | Becton, Dickinson And Company | Two-component medication syringe assembly |
US4650475A (en) * | 1985-07-18 | 1987-03-17 | Carol Smith | Method and apparatus for the injection of pharmaceuticals |
US4861335A (en) | 1985-07-26 | 1989-08-29 | Duoject Medical Systems Inc. | Syringe |
IT1185850B (en) * | 1985-08-02 | 1987-11-18 | Zambon Spa | DROP TANK CAP FOR BOTTLES |
US4675020A (en) | 1985-10-09 | 1987-06-23 | Kendall Mcgaw Laboratories, Inc. | Connector |
US4662878A (en) | 1985-11-13 | 1987-05-05 | Patents Unlimited Ltd. | Medicine vial adaptor for needleless injector |
US4757911A (en) | 1985-12-09 | 1988-07-19 | Abbott Laboratories | Container and closure construction |
AU6775787A (en) | 1985-12-20 | 1987-07-15 | Veech, R.L. | Preparation of electrolyte solutions and containers |
US4632244A (en) | 1986-02-19 | 1986-12-30 | Boris Landau | Multiple chamber flexible container |
US4727985A (en) * | 1986-02-24 | 1988-03-01 | The Boc Group, Inc. | Mixing and dispensing apparatus |
US4722733A (en) * | 1986-02-26 | 1988-02-02 | Intelligent Medicine, Inc. | Drug handling apparatus and method |
US4834152A (en) | 1986-02-27 | 1989-05-30 | Intelligent Medicine, Inc. | Storage receptacle sealing and transfer apparatus |
US4778451A (en) * | 1986-03-04 | 1988-10-18 | Kamen Dean L | Flow control system using boyle's law |
US5575310A (en) | 1986-03-04 | 1996-11-19 | Deka Products Limited Partnership | Flow control system with volume-measuring system using a resonatable mass |
US5211201A (en) | 1986-03-04 | 1993-05-18 | Deka Products Limited Partnership | Intravenous fluid delivery system with air elimination |
US5222946A (en) | 1986-03-04 | 1993-06-29 | Deka Products Limited Partnership | Compact intravenous fluid delivery system |
US5364371A (en) | 1986-03-04 | 1994-11-15 | Deka Products Limited Partnership | Intravenous fluid delivery device |
US5349852A (en) | 1986-03-04 | 1994-09-27 | Deka Products Limited Partnership | Pump controller using acoustic spectral analysis |
US5195986A (en) * | 1986-03-04 | 1993-03-23 | Deka Products Limited Partnership | Integral intravenous fluid delivery device |
US4931048A (en) | 1986-04-07 | 1990-06-05 | Icu Medical, Inc. | Medical device |
US4778453A (en) | 1986-04-07 | 1988-10-18 | Icu Medical, Inc. | Medical device |
US4703864A (en) | 1986-05-01 | 1987-11-03 | Abbott Laboratories | Container cover |
US4735608A (en) | 1986-05-14 | 1988-04-05 | Del F. Kahan | Apparatus for storing and reconstituting antibiotics with intravenous fluids |
US5049129A (en) | 1986-05-29 | 1991-09-17 | Zdeb Brian D | Adapter for passive drug delivery system |
US5074844A (en) | 1986-05-29 | 1991-12-24 | Baxter International Inc. | Passive drug delivery system |
US4781679A (en) | 1986-06-12 | 1988-11-01 | Abbott Laboratories | Container system with integral second substance storing and dispensing means |
SE461765B (en) | 1986-07-10 | 1990-03-26 | Haessle Ab | DEVICE FOR RELEASE OF SUBSTANCE |
US4715854A (en) | 1986-07-17 | 1987-12-29 | Vaillancourt Vincent L | Multidose disposable syringe and method of filling same |
US4871354A (en) | 1986-07-24 | 1989-10-03 | The West Company | Wet-dry bag with lyphozation vial |
IT207945Z2 (en) | 1986-07-25 | 1988-03-14 | Farmitaglia Carlo Erba S P A | DEVICE FOR THE CONNECTION OF A TUBE TO AN APPARATUS SUITABLE FOR COUPLING A SYRINGE TO A BOTTLE CONTAINING A DRUG. |
IT207944Z2 (en) | 1986-07-25 | 1988-03-14 | Erba Farmitalia | LOCKING DEVICE OF A SYRINGE ON A BODY TO WHICH THE SYRINGE MUST BE COUPLED. |
US4786279A (en) | 1986-07-31 | 1988-11-22 | Abbott Laboratories | Container for mixture of materials |
US4693706A (en) | 1986-08-11 | 1987-09-15 | Mark L. Anderson | Two compartment mixing syringe |
US5083031A (en) * | 1986-08-19 | 1992-01-21 | International Sensor Technology, Inc. | Radiation dosimeters |
IE60235B1 (en) | 1986-09-18 | 1994-06-15 | Kabi Pharmacia Ab | "Connector and disposable assembly utilising said connector" |
US4715853A (en) | 1986-09-19 | 1987-12-29 | Ideal Instruments, Inc. | Back-fill syringe |
US4743229A (en) | 1986-09-29 | 1988-05-10 | Collagen Corporation | Collagen/mineral mixing device and method |
WO1988002984A1 (en) | 1986-10-23 | 1988-05-05 | Monell Chemical Senses Center | Enhanced rodent edible with natural attractants |
US4731053A (en) * | 1986-12-23 | 1988-03-15 | Merck & Co., Inc. | Container device for separately storing and mixing two ingredients |
US4832690A (en) | 1987-01-23 | 1989-05-23 | Baxter International Inc. | Needle-pierceable cartridge for drug delivery |
US4784259A (en) | 1987-01-30 | 1988-11-15 | Abbott Laboratories | Container construction with vaned extractor |
US4784658A (en) | 1987-01-30 | 1988-11-15 | Abbott Laboratories | Container construction with helical threaded extractor |
US4886495A (en) | 1987-07-08 | 1989-12-12 | Duoject Medical Systems Inc. | Vial-based prefilled syringe system for one or two component medicaments |
US4986322A (en) * | 1987-03-24 | 1991-01-22 | Societe Semco | System of packaging for ready to use preparations |
US4822351A (en) | 1987-03-25 | 1989-04-18 | Ims Limited | Powder spike holder |
JPH02503272A (en) | 1987-04-02 | 1990-10-11 | ディーアールジー フレックスパック リミティド | A device that brings materials such as drugs into contact with liquids |
US4782841A (en) | 1987-04-07 | 1988-11-08 | Icu Medical, Inc. | Medical device |
US4816024A (en) * | 1987-04-13 | 1989-03-28 | Icu Medical, Inc. | Medical device |
SE457417B (en) * | 1987-04-14 | 1988-12-27 | Astra Meditec Ab | AUTOMATIC SQUARE SPRAY, PROCEDURE FOR MIXING AND INJECTION WITH THE SPRAYER AND AMPULA FOR PRIVATE CHAMBER SPRAY |
US4927605A (en) | 1987-04-22 | 1990-05-22 | Wadley Technologies, Inc. | Specimen collection and sampling container |
US4842028A (en) | 1987-05-13 | 1989-06-27 | Baxter International Inc. | Fluid transfer apparatus |
GB2205549B (en) * | 1987-05-18 | 1991-03-20 | Otsuka Pharma Co Ltd | Self-supportable parenteral bottle of synthetic resin |
CH686778A5 (en) * | 1987-05-29 | 1996-06-28 | Vifor Medical Ag | Container for separate storage of active compounds and their subsequent mixing. |
IL86799A (en) | 1987-07-02 | 1993-03-15 | Kabi Pharmacia Ab | Method and device for injection |
US4768568A (en) | 1987-07-07 | 1988-09-06 | Survival Technology, Inc. | Hazardous material vial apparatus providing expansible sealed and filter vented chambers |
US5554125A (en) | 1987-07-08 | 1996-09-10 | Reynolds; David L. | Prefilled vial syringe |
US5364369A (en) | 1987-07-08 | 1994-11-15 | Reynolds David L | Syringe |
DE3726064A1 (en) | 1987-08-06 | 1989-02-16 | Fresenius Ag | PACKING UNIT FOR MEDICAL PURPOSES |
US4819659A (en) | 1987-09-21 | 1989-04-11 | Icu Medical, Inc. | Blood withdrawal device with movable needle guard member |
IT211830Z2 (en) * | 1987-09-22 | 1989-05-25 | Farmitalia Carl Erba S P A | SAFETY DEVICE FOR THE INTRODUCTION AND WITHDRAWAL OF LIQUIDS IN AND FROM DRUG BOTTLES AND SIMILAR. |
JPS6485653A (en) | 1987-09-28 | 1989-03-30 | Terumo Corp | Drug receiving container |
GB2211104B (en) | 1987-10-13 | 1991-10-02 | Wilson Dr Louise Caroline | Syringe arrangment |
IT1231892B (en) | 1987-10-14 | 1992-01-15 | Farmitalia Carlo Erba S P A Mi | APPARATUS WITH SAFETY LOCKING ORGANS FOR CONNECTION OF A SYRINGE TO A BOTTLE CONTAINING A DRUG |
US4804366A (en) * | 1987-10-29 | 1989-02-14 | Baxter International Inc. | Cartridge and adapter for introducing a beneficial agent into an intravenous delivery system |
US4850978A (en) | 1987-10-29 | 1989-07-25 | Baxter International Inc. | Drug delivery cartridge with protective cover |
GB8726062D0 (en) | 1987-11-06 | 1987-12-09 | Plaspharm Uk Ltd | Fluid dispensing devices |
US5510115A (en) | 1987-11-16 | 1996-04-23 | Baxter Travenol Laboratories, Inc. | Method and composition for administration of beneficial agent by controlled dissolution |
US5030203A (en) | 1987-11-16 | 1991-07-09 | Baxter International Inc. | Ampule for controlled administration of beneficial agent |
US4948000A (en) | 1987-11-20 | 1990-08-14 | Grabenkort Richard W | Container shrouds |
US5334188A (en) | 1987-12-07 | 1994-08-02 | Nissho Corporation | Connector with injection site |
IL88667A (en) | 1987-12-28 | 1992-02-16 | Abbott Lab | Container with improved ratchet teeth interlock |
US5100394A (en) * | 1988-01-25 | 1992-03-31 | Baxter International Inc. | Pre-slit injection site |
DE8802443U1 (en) | 1988-02-25 | 1988-09-01 | Schiwa Gmbh, 4519 Glandorf, De | |
DE3806562A1 (en) | 1988-03-01 | 1989-09-14 | Alpha Therapeutic Gmbh | TWO CHAMBER SYRINGE WITH A FILLING OF ACTIVITY SENSITIVE HUMAN PROTEIN AS AN ACTIVE SUBSTANCE |
JPH021277A (en) | 1988-03-31 | 1990-01-05 | Fujisawa Pharmaceut Co Ltd | Infusion container |
US5176673A (en) * | 1988-06-02 | 1993-01-05 | Piero Marrucchi | Method and device for manipulating and transferring products between confined volumes |
ATE179632T1 (en) | 1988-06-02 | 1999-05-15 | Piero Marrucchi | DEVICE FOR TREATING AND TRANSFERING SUBSTANCES BETWEEN ENCLOSED ROOMS |
JP2675075B2 (en) | 1988-06-10 | 1997-11-12 | 株式会社新素材総合研究所 | Container with contents |
US4975589A (en) * | 1988-07-22 | 1990-12-04 | The Harshaw Chemical Company | Thermoluminescent dosimeter with improved card holder |
US4874368A (en) | 1988-07-25 | 1989-10-17 | Micromedics, Inc. | Fibrin glue delivery system |
US4871463A (en) | 1988-08-23 | 1989-10-03 | Sepratech | Vertical reaction vessel |
US4978337A (en) | 1988-09-08 | 1990-12-18 | Alza Corporation | Formulation chamber with exterior electrotransport delivery device |
US4898209A (en) * | 1988-09-27 | 1990-02-06 | Baxter International Inc. | Sliding reconstitution device with seal |
DE8812460U1 (en) | 1988-10-03 | 1988-12-22 | Schiwa Gmbh, 4519 Glandorf, De | |
DE3834566A1 (en) | 1988-10-11 | 1990-04-12 | Fresenius Ag | CONTAINER FOR STERILE, SEPARATE STORAGE OF AT LEAST TWO SUBSTANCES AND FOR MIXING THEREOF |
USD323389S (en) | 1988-10-17 | 1992-01-21 | Fujisawa Pharmaceutical Co., Ltd. | Medical fluid container |
US4936829A (en) | 1988-10-19 | 1990-06-26 | Baxter International Inc. | Drug delivery apparatus including beneficial agent chamber with chimney for a directed flow path |
US5269350A (en) | 1988-10-20 | 1993-12-14 | Galloway Company | Aseptic fluid transfer apparatus and methods |
US5252484A (en) * | 1988-11-29 | 1993-10-12 | Minnesota Mining And Manufacturing Company | Rapid read-out biological indicator |
US5147324A (en) | 1988-12-06 | 1992-09-15 | C. R. Bard, Inc. | Prefilled syringe delivery system |
US5156598A (en) | 1988-12-06 | 1992-10-20 | C. R. Bard, Inc. | Prefilled syringe delivery system |
CA2006582A1 (en) | 1988-12-27 | 1990-06-27 | Gabriel Meyer | Storage and transfer bottle for storing two components of a medicinal substance |
US4969883A (en) | 1989-01-03 | 1990-11-13 | Gilbert Michael D | Medicament vial end cap membrane piercing device |
US5032117A (en) | 1989-01-30 | 1991-07-16 | Motta Louis J | Tandem syringe |
US5250028A (en) | 1989-02-15 | 1993-10-05 | Alza Corporation | Intravenous system for delivering a beneficial agent using permeability enhancers |
US4985016A (en) * | 1989-02-15 | 1991-01-15 | Alza Corporation | Intravenous system for delivering a beneficial agent |
US4969871A (en) | 1989-02-15 | 1990-11-13 | Alza Corporation | Intravenous system for delivering a beneficial agent |
US5196419A (en) | 1989-02-28 | 1993-03-23 | Imperial Chemical Industries Plc | Heterocyclic cyclic ethers |
US5009654A (en) * | 1989-03-10 | 1991-04-23 | Baxter International Inc. | Sterile product and method for sterilizing and assembling such product |
US4927013A (en) | 1989-04-12 | 1990-05-22 | Eastman Kodak Company | Package for storing and remixing two materials |
US5049754A (en) * | 1989-04-24 | 1991-09-17 | International Sensor Technology, Inc. | Radiation dosimeter disassembly, assembly and reading apparatuses and methods |
US4865354A (en) | 1989-05-09 | 1989-09-12 | Allen Jerry L | Conduit coupler |
US5152965A (en) | 1989-06-02 | 1992-10-06 | Abbott Laboratories | Two-piece reagent container assembly |
JP3108077B2 (en) | 1989-06-08 | 2000-11-13 | 住友製薬株式会社 | Formulation dosing device |
US4944736A (en) | 1989-07-05 | 1990-07-31 | Holtz Leonard J | Adaptor cap for centering, sealing, and holding a syringe to a bottle |
US4997430A (en) * | 1989-09-06 | 1991-03-05 | Npbi Nederlands Produktielaboratorium Voor Bloedtransfusieapparatuur En Infusievloeistoffen B.V. | Method of and apparatus for administering medicament to a patient |
US5116315A (en) | 1989-10-03 | 1992-05-26 | Hemaedics, Inc. | Biological syringe system |
US5104375A (en) | 1989-10-16 | 1992-04-14 | Johnson & Johnson Medical, Inc. | Locking holder for a pair of syringes and method of use |
US4979942A (en) | 1989-10-16 | 1990-12-25 | Johnson & Johnson Medical, Inc. | Two component syringe delivery system |
US5080652A (en) * | 1989-10-31 | 1992-01-14 | Block Medical, Inc. | Infusion apparatus |
US4994056A (en) * | 1989-11-09 | 1991-02-19 | Ikeda Daniel P | Unit dose medicament storing and mixing system |
CA2045408A1 (en) | 1989-11-13 | 1991-05-14 | Gabriel Meyer | Storage bottle containing a constituent of a medicinal solution_ |
US5257985A (en) | 1989-12-04 | 1993-11-02 | Richard Puhl | Multi-chamber intravenous bag apparatus |
US5045081A (en) | 1990-01-16 | 1991-09-03 | Dysarz Edward D | Trap in barrel one handed retractable vial filling device |
US5074849A (en) | 1990-01-22 | 1991-12-24 | Sachse Hans Ernst | Ureter drainage tube with fixable auxiliary tube |
US5084040A (en) * | 1990-01-25 | 1992-01-28 | The West Company, Incorporated | Lyophilization device |
US5304163A (en) | 1990-01-29 | 1994-04-19 | Baxter International Inc. | Integral reconstitution device |
DE69111480T2 (en) | 1990-02-14 | 1996-03-14 | Shinsozai Sogo Kenkyusho Kk | Filled and sealed, independent mixing container. |
US5289585A (en) * | 1990-03-26 | 1994-02-22 | Siemens Nixdorf Informationssysteme Ag | Multiprocessor system having a system bus for the coupling of several processing units with appertaining private cache memories and a common main memory |
US5222947A (en) | 1990-04-18 | 1993-06-29 | Amico Elio D | Self recapping injection needle assembly |
US5514090A (en) | 1990-04-24 | 1996-05-07 | Science Incorporated | Closed drug delivery system |
US5328464A (en) | 1990-04-24 | 1994-07-12 | Science Incorporated | Closed drug delivery system |
US5267957A (en) | 1990-04-24 | 1993-12-07 | Science Incorporated | Closed drug delivery system |
US5336180A (en) | 1990-04-24 | 1994-08-09 | Science Incorporated | Closed drug delivery system |
US5102408A (en) | 1990-04-26 | 1992-04-07 | Hamacher Edward N | Fluid mixing reservoir for use in medical procedures |
CA2016870C (en) | 1990-05-15 | 1994-03-29 | Arnie Drudik | Dispenser for storing and mixing several components |
US5257987A (en) | 1990-05-21 | 1993-11-02 | Pharmetrix Corporation | Controlled release osmotic infusion system |
US5373966A (en) | 1990-06-01 | 1994-12-20 | O'reilly; Daniel J. | Single use dispensing sachets and method of and means for manufacture of same |
US5169388A (en) | 1990-06-07 | 1992-12-08 | Gensia Pharmaceuticals, Inc. | Pressure-activated medication dispenser |
JPH0628137Y2 (en) * | 1990-06-21 | 1994-08-03 | 株式会社ニッショー | Closure in a flexible tube |
US5176634A (en) * | 1990-08-02 | 1993-01-05 | Mcgaw, Inc. | Flexible multiple compartment drug container |
US5209201A (en) | 1990-08-10 | 1993-05-11 | Honda Giken Kogyo Kabushiki Kaisha | Internal combustion engine |
US5167642A (en) | 1990-08-27 | 1992-12-01 | Baxter International Inc. | Sheath for a blunt cannula |
US5049135A (en) | 1990-09-18 | 1991-09-17 | Code Blue Medical Corporation | Medical lavage apparatus |
JP2980663B2 (en) | 1990-10-05 | 1999-11-22 | テルモ株式会社 | Bag connection |
US5125908A (en) | 1990-10-19 | 1992-06-30 | Cohen Milton J | Hypodermic syringe with protective holder |
EP0513364B1 (en) | 1990-11-07 | 1995-07-19 | Otsuka Pharmaceutical Factory, Inc. | Multi-chamber vessel |
US5114411A (en) | 1990-11-19 | 1992-05-19 | Habley Medical Technology Corporation | Multi-chamber vial |
US5352196A (en) | 1990-11-19 | 1994-10-04 | Habley Medical Technology Corporation | Mixing vial |
US5188615A (en) * | 1990-11-19 | 1993-02-23 | Habley Medical Technology Corp. | Mixing vial |
DK288590D0 (en) | 1990-12-04 | 1990-12-04 | Michael Morris | MIXTURE / SOLUTION SPRAY FOR CYTOSTATICS FOR MEDICAL TREATMENT OF CANCER PATIENTS |
US5209347A (en) | 1990-12-05 | 1993-05-11 | Clintec Nutrition Company | Internal tear seal dual bag |
US5232029A (en) | 1990-12-06 | 1993-08-03 | Abbott Laboratories | Additive device for vial |
US5171214A (en) | 1990-12-26 | 1992-12-15 | Abbott Laboratories | Drug storage and delivery system |
CA2057771A1 (en) | 1990-12-31 | 1992-07-01 | Richard W. Grabenkort | Flexible container with integral protective cover |
EP0495445A1 (en) | 1991-01-16 | 1992-07-22 | Takeda Chemical Industries, Ltd. | Dual-chamber type syringe |
US5360410A (en) | 1991-01-16 | 1994-11-01 | Senetek Plc | Safety syringe for mixing two-component medicaments |
US5490848A (en) * | 1991-01-29 | 1996-02-13 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | System for creating on site, remote from a sterile environment, parenteral solutions |
US5122123A (en) | 1991-01-30 | 1992-06-16 | Vaillancourt Vincent L | Closed system connector assembly |
US5064059A (en) | 1991-02-05 | 1991-11-12 | Abbott Laboratories | Dual container system with extractor for stopper |
ES1016828Y (en) | 1991-02-22 | 1992-06-01 | Instituto De Biologia Y Sueroterapia, S.A. | DEVICE FOR THE TRANSFER OF LIQUIDS BETWEEN FLEXIBLE AND ROAD CONTAINERS. |
US5116316A (en) | 1991-02-25 | 1992-05-26 | Baxter International Inc. | Automatic in-line reconstitution system |
US5196001A (en) * | 1991-03-05 | 1993-03-23 | Ti Kao | Devices and methods for preparing pharmaceutical solutions |
DE4107223C1 (en) | 1991-03-07 | 1992-09-10 | Fresenius Ag, 6380 Bad Homburg, De | |
EP0503867B1 (en) | 1991-03-08 | 1997-02-05 | Material Engineering Technology Laboratory, Inc. | storing and mixing apparatus |
US5195658A (en) * | 1991-03-12 | 1993-03-23 | Toyo Bussan Kabushiki Kaisha | Disposable container |
JPH04302810A (en) * | 1991-03-29 | 1992-10-26 | Victor Co Of Japan Ltd | Thin-film magnetic head |
IT223172Z2 (en) | 1991-04-09 | 1995-06-13 | Tecnomedica Ricerche Srl | DEVICE FOR THE ADMINISTRATION OF DRUGS, PARTICULARLY TWO-COMPONENT PHARMA-CI |
US5199948A (en) | 1991-05-02 | 1993-04-06 | Mcgaw, Inc. | Needleless valve |
US5181909A (en) * | 1991-05-15 | 1993-01-26 | Mcfarlane Richard H | Ampule-container medical syringe and methods |
JPH05123377A (en) | 1991-05-29 | 1993-05-21 | Fujisawa Pharmaceut Co Ltd | Infusion device |
US5368586A (en) | 1991-06-21 | 1994-11-29 | Npbi Nederlands Produktielaboratorium Voor Bloedtransfusieapparatuur En Infusievloeistoffen B.V. | Closure for a drug-vial |
US5186323A (en) * | 1991-06-24 | 1993-02-16 | Pfleger Frederick W | Dual compartment mixing container |
US5158546A (en) | 1991-08-07 | 1992-10-27 | Habley Medical Technology Corp. | Controlled action self-mixing vial |
JPH05103819A (en) | 1991-08-08 | 1993-04-27 | Nissho Corp | Medicine receiving container |
DE4127650C1 (en) | 1991-08-21 | 1993-02-25 | Arzneimittel Gmbh Apotheker Vetter & Co Ravensburg, 7980 Ravensburg, De | |
NL9101422A (en) | 1991-08-23 | 1993-03-16 | Doornes Transmissie Bv | ROTARY PUMP. |
JP3065735B2 (en) | 1991-08-29 | 2000-07-17 | 株式会社ニッショー | Drug container and drug solution injector using the same |
JP2593374B2 (en) | 1991-08-30 | 1997-03-26 | 日精樹脂工業株式会社 | Injection molding machine molding condition setting method |
US5308347A (en) | 1991-09-18 | 1994-05-03 | Fujisawa Pharmaceutical Co., Ltd. | Transfusion device |
US5246142A (en) | 1991-09-26 | 1993-09-21 | Dipalma Elio | Device for storing two products separately and subsequently mixing them |
DK166691D0 (en) | 1991-09-30 | 1991-09-30 | Unes As | MULTI-COMPONENT PROJECT |
US5303751A (en) | 1991-10-04 | 1994-04-19 | Fresenius Ag | Spiked bag packaging system |
US5188610A (en) | 1991-10-18 | 1993-02-23 | Vetrisystems, Inc. | Fluid dispensing apparatus |
US5356380A (en) | 1991-10-23 | 1994-10-18 | Baxter International Inc. | Drug delivery system |
US5352191A (en) | 1991-10-25 | 1994-10-04 | Fujisawa Pharmaceutical Co., Ltd. | Transfusion device |
US5259843A (en) | 1991-11-14 | 1993-11-09 | Kawasumi Laboratories Inc. | Medical connector for attaching to liquid introducing tube |
SE9103395D0 (en) | 1991-11-18 | 1991-11-18 | Gambro Ab | SYSTEM USING ENSTERIL MEDICAL SOLUTION CONTAINING GLUCOSE OR GLUCOSE-LIKE SUBSTANCES AND A SOLUTION INTENDED FOR THIS SYSTEM |
US5304165A (en) | 1991-12-09 | 1994-04-19 | Habley Medical Technology Corporation | Syringe-filling medication dispenser |
US5259954A (en) | 1991-12-16 | 1993-11-09 | Sepratech, Inc. | Portable intravenous solution preparation apparatus and method |
US5247972A (en) | 1991-12-17 | 1993-09-28 | Whittier Medical, Inc. | Alignment guide for hypodermic syringe |
US5289858A (en) | 1991-12-18 | 1994-03-01 | Abbott Laboratories | System for accommodating withdrawal of liquid from a bulk supply |
US5332399A (en) | 1991-12-20 | 1994-07-26 | Abbott Laboratories | Safety packaging improvements |
US5226878A (en) | 1992-01-10 | 1993-07-13 | Whitaker Designs, Inc. | Two-container system for mixing medicament with diluent including safety wand to protect against improper titration |
JPH05212090A (en) * | 1992-02-04 | 1993-08-24 | Material Eng Tech Lab Inc | Transfusion container |
US5304130A (en) | 1992-02-26 | 1994-04-19 | Baxter International Inc. | Container for the controlled administration of a beneficial agent |
US5330464A (en) | 1992-03-11 | 1994-07-19 | Baxter International Inc. | Reliable breakable closure mechanism |
DE69330568T2 (en) * | 1992-03-12 | 2001-11-22 | Honda Motor Co Ltd | Vibration and noise control system for motor vehicles |
JP3146465B2 (en) | 1992-03-13 | 2001-03-19 | 株式会社ニッショー | Chemical injection device |
JP3192743B2 (en) | 1992-03-17 | 2001-07-30 | 株式会社ブリヂストン | Method and apparatus for molding cylindrical member |
US5211285A (en) | 1992-03-19 | 1993-05-18 | Habley Medical Technology Corporation | Telescoping, pharmaceutical mixing container |
EP0562671B1 (en) | 1992-03-27 | 1996-05-29 | Duphar International Research B.V | Automatic injector |
CA2093560C (en) | 1992-04-10 | 2005-06-07 | Minoru Honda | Fluid container |
SE470396B (en) | 1992-12-04 | 1994-02-14 | Dicamed Ab | Valve device for aseptic injection and withdrawal of medical fluid in / out of containers and its use |
SE9201247D0 (en) | 1992-04-21 | 1992-04-21 | Kabi Pharmacia Ab | INJECTION DEVICE |
JP2550256B2 (en) | 1992-04-22 | 1996-11-06 | 昭和電工株式会社 | Medical bag |
NZ247392A (en) * | 1992-04-30 | 1995-05-26 | Takeda Chemical Industries Ltd | Prefilled syringe containing two substances mixed before injection |
JP2605345Y2 (en) | 1992-05-01 | 2000-07-10 | 株式会社大塚製薬工場 | Drug container |
US5423421A (en) | 1992-05-03 | 1995-06-13 | Otsuka Pharmaceutical Factory, Inc. | Containers having plurality of chambers |
US5281198A (en) * | 1992-05-04 | 1994-01-25 | Habley Medical Technology Corporation | Pharmaceutical component-mixing delivery assembly |
JPH05317383A (en) | 1992-05-19 | 1993-12-03 | Nissho Corp | Solution container equipped with means for communicating with chemical container |
US5279576A (en) * | 1992-05-26 | 1994-01-18 | George Loo | Medication vial adapter |
US5232109A (en) | 1992-06-02 | 1993-08-03 | Sterling Winthrop Inc. | Double-seal stopper for parenteral bottle |
GB9211912D0 (en) | 1992-06-04 | 1992-07-15 | Drg Flexpak Ltd | Vial connector system |
US5484410A (en) * | 1992-06-24 | 1996-01-16 | Science Incorporated | Mixing and delivery system |
US5385546A (en) * | 1992-06-24 | 1995-01-31 | Science Incorporated | Mixing and delivering system |
US5385545A (en) * | 1992-06-24 | 1995-01-31 | Science Incorporated | Mixing and delivery system |
SE9202108D0 (en) | 1992-07-07 | 1992-07-07 | Kabi Pharmacia Ab | DUAL-CHAMBER INJECTION CARTRIDGE |
JPH07509A (en) * | 1992-07-31 | 1995-01-06 | Nissho Corp | Medicinal liquid injecting device |
US5226900A (en) | 1992-08-03 | 1993-07-13 | Baxter International Inc. | Cannula for use in drug delivery systems and systems including same |
US5531683A (en) | 1992-08-13 | 1996-07-02 | Science Incorporated | Mixing and delivery syringe assembly |
US5330426A (en) | 1992-08-13 | 1994-07-19 | Science Incorporated | Mixing and delivery syringe assembly |
US5279583A (en) * | 1992-08-28 | 1994-01-18 | Shober Jr Robert C | Retractable injection needle assembly |
US5344417A (en) | 1992-09-11 | 1994-09-06 | Becton, Dickinson And Company | Universal fitting for inoculation receptacles |
AU5132993A (en) * | 1992-09-21 | 1994-04-12 | Habley Medical Technology Corporation | Device and method for containing an ampule and transferring liquid within the ampule to a container |
US5287961A (en) * | 1992-10-23 | 1994-02-22 | W.R. Grace & Co.-Conn. | Multi-compartment package having improved partition strip |
IT1258699B (en) | 1992-11-06 | 1996-02-27 | Italia Farina | BAG OF CONTAINMENT OF AT LEAST TWO SEPARATE FLUIDS TO MIX. |
US5286257A (en) * | 1992-11-18 | 1994-02-15 | Ultradent Products, Inc. | Syringe apparatus with detachable mixing and delivery tip |
US5385547A (en) * | 1992-11-19 | 1995-01-31 | Baxter International Inc. | Adaptor for drug delivery |
US5547471A (en) | 1992-11-19 | 1996-08-20 | Baxter International Inc. | In-line drug delivery device for use with a standard IV administration set and a method for delivery |
US5484406A (en) * | 1992-11-19 | 1996-01-16 | Baxter International Inc. | In-line drug delivery device for use with a standard IV administration set and a method for delivery |
US5306242A (en) | 1992-12-15 | 1994-04-26 | Abbott Laboratories | Recirculation through plural pump cassettes for a solution compounding apparatus |
WO1994013344A1 (en) | 1992-12-15 | 1994-06-23 | Gabriel Meyer | Device for preparing a medicinal substance solution, suspension or emulsion |
JP3091069B2 (en) | 1992-12-28 | 2000-09-25 | 三井化学株式会社 | Resin laminate and its use |
GB2274064B (en) | 1993-01-12 | 1996-04-17 | David Lile Reynolds | Intravenous infusion of pharmaceuticals |
US5353961A (en) | 1993-01-15 | 1994-10-11 | Reseal International Limited Partnership | Dual chamber dispenser |
AU667623B2 (en) | 1993-01-19 | 1996-03-28 | Baxter International Inc. | Multiple chamber container |
CA2114348A1 (en) * | 1993-01-27 | 1994-07-28 | Richard W. Grabenkort | Method and apparatus for assembling containers |
JPH06239352A (en) | 1993-02-05 | 1994-08-30 | Nissho Corp | Solution injection set |
US5492219A (en) * | 1993-02-24 | 1996-02-20 | Illinois Tool Works Inc. | Plural compartment package |
JPH06259799A (en) | 1993-03-04 | 1994-09-16 | Nikon Corp | Method and device for reproducing optical disk |
AU5637094A (en) | 1993-03-16 | 1994-09-22 | Clintec Nutrition Company | Peelable seal and container having same |
IT1262784B (en) | 1993-03-29 | 1996-07-04 | SAFETY DEVICE FOR COLLECTIONS AND INFUSIONS | |
US5334180A (en) | 1993-04-01 | 1994-08-02 | Abbott Laboratories | Sterile formed, filled and sealed flexible container |
US5334178A (en) | 1993-04-14 | 1994-08-02 | Habley Medical Technology Corporation | Pierceable pharmaceutical container closure with check valve |
CA2120315C (en) * | 1993-04-30 | 2001-05-15 | Joel L. Williams | Medical articles and process therefor |
US5509898A (en) | 1993-05-10 | 1996-04-23 | Material Engineering Technology Laboratory, Inc. | Container for therapeutic use |
CA2124970A1 (en) | 1993-06-29 | 1994-12-30 | R. Hayes Helgren | Pointed adapter for blunt entry device |
US5429614A (en) | 1993-06-30 | 1995-07-04 | Baxter International Inc. | Drug delivery system |
WO1995001133A1 (en) | 1993-06-30 | 1995-01-12 | Baxter International Inc. | Vial adapter |
US5593028A (en) * | 1993-07-02 | 1997-01-14 | Habley Medical Technology Corporation | Multi-pharmaceutical storage, mixing and dispensing vial |
US5335773A (en) | 1993-07-02 | 1994-08-09 | Habley Medical Technology Corporation | Multi-pharmaceutical storage, mixing and dispensing vial |
US5330048A (en) | 1993-07-09 | 1994-07-19 | Habley Medical Technology Corporation | Controlled access mixing vial |
US5397303A (en) | 1993-08-06 | 1995-03-14 | River Medical, Inc. | Liquid delivery device having a vial attachment or adapter incorporated therein |
US5398851A (en) | 1993-08-06 | 1995-03-21 | River Medical, Inc. | Liquid delivery device |
WO1995007066A1 (en) | 1993-09-07 | 1995-03-16 | Debiotech S.A. | Syringe device for mixing two compounds |
US5462526A (en) | 1993-09-15 | 1995-10-31 | Mcgaw, Inc. | Flexible, sterile container and method of making and using same |
US5540674A (en) | 1993-09-28 | 1996-07-30 | Abbott Laboratories | Solution container with dual use access port |
US5423796A (en) | 1993-10-08 | 1995-06-13 | United States Surgical Corporation | Trocar with electrical tissue penetration indicator |
US5472022A (en) | 1993-11-02 | 1995-12-05 | Genentech, Inc. | Injection pen solution transfer apparatus and method |
US5538506A (en) | 1993-11-03 | 1996-07-23 | Farris; Barry | Prefilled fluid syringe |
US5458593A (en) | 1993-11-24 | 1995-10-17 | Bayer Corporation | Dockable bag system and method |
US5429256A (en) | 1994-01-24 | 1995-07-04 | Kestenbaum; Alan D. | Drug withdrawal system for container |
US5489266A (en) * | 1994-01-25 | 1996-02-06 | Becton, Dickinson And Company | Syringe assembly and method for lyophilizing and reconstituting injectable medication |
US5522804A (en) | 1994-02-15 | 1996-06-04 | Lynn; Lawrence A. | Aspiration, mixing, and injection syringe |
US5554128A (en) | 1994-03-09 | 1996-09-10 | Joseph K. Andonian | Syringe and vial connector |
US5620434A (en) | 1994-03-14 | 1997-04-15 | Brony; Seth K. | Medicine vial link for needleless syringes |
US5474540A (en) | 1994-03-25 | 1995-12-12 | Micromedics, Inc. | Fluid separation control attachment for physiologic glue applicator |
US5535746A (en) | 1994-03-29 | 1996-07-16 | Sterling Winthrop Inc. | Prefilled syringe for use with power injector |
JP3383966B2 (en) | 1994-05-27 | 2003-03-10 | ニプロ株式会社 | Prefilled syringe |
US5595314A (en) * | 1994-06-02 | 1997-01-21 | Automatic Liquid Packaging, Inc. | Torque-resistant closure for a hermetically sealed container |
EP0692235A1 (en) | 1994-07-14 | 1996-01-17 | International Medication Systems (U.K.) Ltd. | Mixing & dispensing apparatus |
US5526853A (en) | 1994-08-17 | 1996-06-18 | Mcgaw, Inc. | Pressure-activated medication transfer system |
US5509912A (en) | 1994-10-24 | 1996-04-23 | Vlv Associates | Connector |
US5494190A (en) * | 1994-12-29 | 1996-02-27 | Minnesota Mining And Manufacturing Company | Method and combination for dispensing two part sealing material |
US5533973A (en) | 1995-01-13 | 1996-07-09 | Abbott Laboratories | Alteration of nutritional product during enteral tube feeding |
US5492147A (en) * | 1995-01-17 | 1996-02-20 | Aeroquip Corporation | Dry break coupling |
US5569193A (en) | 1995-03-22 | 1996-10-29 | Abbott Laboratories | Syringe system accommodating separately storable prefilled containers for two constituents |
US5566729A (en) | 1995-04-06 | 1996-10-22 | Abbott Laboratories | Drug reconstitution and administration system |
DE19513666C1 (en) | 1995-04-11 | 1996-11-28 | Behringwerke Ag | Device for bringing together a first liquid and a second solid or liquid component by means of negative pressure under sterile conditions |
US5603695A (en) * | 1995-06-07 | 1997-02-18 | Erickson; Kim | Device for alkalizing local anesthetic injection medication |
US5584808A (en) | 1995-06-20 | 1996-12-17 | Healy; Patrick M. | Valve mechanism |
CA2159531A1 (en) * | 1995-09-29 | 1997-03-30 | Courtland B. Lawrence | Method for monitoring absorbed dose in an electron beam |
US5596193A (en) * | 1995-10-11 | 1997-01-21 | California Institute Of Technology | Miniature quadrupole mass spectrometer array |
US5897526A (en) | 1996-06-26 | 1999-04-27 | Vaillancourt; Vincent L. | Closed system medication administering system |
US6159192A (en) | 1997-12-04 | 2000-12-12 | Fowles; Thomas A. | Sliding reconstitution device with seal |
AT406805B (en) * | 1998-02-06 | 2000-09-25 | Bse Mediscan Ges M B H & Co Kg | METHOD FOR TREATING A GOOD |
US6378714B1 (en) | 1998-04-20 | 2002-04-30 | Becton Dickinson And Company | Transferset for vials and other medical containers |
US6022339A (en) * | 1998-09-15 | 2000-02-08 | Baxter International Inc. | Sliding reconstitution device for a diluent container |
US6340590B1 (en) | 1998-11-12 | 2002-01-22 | John R. Gillis | Verification of thermal sterilization |
US6140657A (en) * | 1999-03-17 | 2000-10-31 | American International Technologies, Inc. | Sterilization by low energy electron beam |
US6232610B1 (en) * | 1999-06-17 | 2001-05-15 | Gex Corporation | Dosimetry apparatus and method |
US6475433B2 (en) | 2000-02-01 | 2002-11-05 | Ebw Electronics, Inc. | Method and apparatus for verifying ultraviolet sterilization |
US6543098B2 (en) | 2001-03-02 | 2003-04-08 | Tektronix, Inc. | Printed circuit board mounting facility |
US6624427B2 (en) | 2001-09-04 | 2003-09-23 | Asahi Techno Glass Corporation | Dosimeter glass element, method for manufacturing same, and dosimeter holder |
US7270790B2 (en) * | 2002-04-11 | 2007-09-18 | Baxter International Inc. | Sterilizer monitoring and controlling system and method |
-
2003
- 2003-12-23 US US10/745,466 patent/US7641851B2/en not_active Expired - Fee Related
-
2004
- 2004-12-01 ES ES04812618T patent/ES2386894T3/en active Active
- 2004-12-01 MX MXPA06006475A patent/MXPA06006475A/en active IP Right Grant
- 2004-12-01 AU AU2004311924A patent/AU2004311924B2/en not_active Ceased
- 2004-12-01 CN CNB2004800385051A patent/CN100556462C/en not_active Expired - Fee Related
- 2004-12-01 ES ES12159706.6T patent/ES2473315T3/en active Active
- 2004-12-01 EP EP04812618A patent/EP1708759B1/en not_active Not-in-force
- 2004-12-01 EP EP12159706.6A patent/EP2465544B1/en not_active Not-in-force
- 2004-12-01 PL PL04812618T patent/PL1708759T3/en unknown
- 2004-12-01 WO PCT/US2004/040146 patent/WO2005065728A1/en active Application Filing
- 2004-12-01 AT AT04812618T patent/ATE554794T1/en active
- 2004-12-01 CA CA2546846A patent/CA2546846C/en not_active Expired - Fee Related
- 2004-12-01 JP JP2006547027A patent/JP2007516774A/en not_active Withdrawn
-
2009
- 2009-12-18 US US12/642,282 patent/US8022375B2/en not_active Expired - Lifetime
-
2010
- 2010-09-15 AU AU2010219435A patent/AU2010219435B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
AU2004311924A1 (en) | 2005-07-21 |
AU2010219435A1 (en) | 2010-10-07 |
CN1897982A (en) | 2007-01-17 |
WO2005065728A1 (en) | 2005-07-21 |
US8022375B2 (en) | 2011-09-20 |
US7641851B2 (en) | 2010-01-05 |
US20100140515A1 (en) | 2010-06-10 |
EP1708759B1 (en) | 2012-04-25 |
EP1708759A1 (en) | 2006-10-11 |
ES2386894T3 (en) | 2012-09-05 |
EP2465544B1 (en) | 2014-03-19 |
ES2473315T3 (en) | 2014-07-04 |
JP2007516774A (en) | 2007-06-28 |
PL1708759T3 (en) | 2012-09-28 |
AU2010219435B2 (en) | 2012-03-15 |
MXPA06006475A (en) | 2006-08-23 |
EP2465544A1 (en) | 2012-06-20 |
CN100556462C (en) | 2009-11-04 |
ATE554794T1 (en) | 2012-05-15 |
AU2004311924B2 (en) | 2010-06-17 |
US20050135965A1 (en) | 2005-06-23 |
CA2546846A1 (en) | 2005-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8022375B2 (en) | Method and apparatus for validation of sterilization | |
Harrington et al. | Sterilization and disinfection of biomaterials for medical devices | |
US8802018B2 (en) | Apparatus and method for radiation processing of fluent food products | |
JP2001524056A (en) | Technology for electronic sterilization of open containers | |
US20030190272A1 (en) | Sterilization containers and methods for radiation sterilization of liquid products | |
Gotzmann et al. | Low-energy electron-beam treatment as alternative for on-site sterilization of highly functionalized medical products–a feasibility study | |
US8541740B2 (en) | Device and method for electron beam energy verification | |
Fairand et al. | Radiation sterilization | |
Vadrucci et al. | Parchment processing and analysis: ionizing radiation treatment by the REX source and multidisciplinary approach characterization | |
Soliman et al. | Dosimetric studies for gamma radiation validation of medical devices | |
Urgiles et al. | Electron beam irradiation for microbial reduction on spacecraft components | |
Jacobs | Validation of the radiation sterilization of pharmaceuticals | |
Cleghorn et al. | Electron sterilization validation techniques using the controlled depth of sterilization process | |
Butson et al. | Dosimetry of blood irradiation with radiochromic film | |
US6464937B2 (en) | Ultrapure sterilization of microbiological test media by electron beam irradiation | |
Sharma et al. | Achieving sterility in biomedical and pharmaceutical products (part-II): radiation sterilization | |
US20220175986A1 (en) | Decontamination method | |
Booth | Revival: Sterilization Validation and Routine Operation Handbook (2001): Radiation | |
Booth | Industrial sterilization technologies: principles and overview | |
Razmukhamedov et al. | DETERMINATION OF OPTIMAL IRRADIATION DOSE OF MEDICAL PRODUCTS | |
Lazurik et al. | Modeling of processes of an irradiation for industrial radiation technologies | |
Gant et al. | Radiation processing and high-dose dosimetry at ANSTO | |
Gritsan et al. | Sterilization of pharmaceuticals at a LU-10 electron accelerator of NSC KIPT | |
Masefield et al. | Current North American Practices in Gamma Sterilization | |
Pillai et al. | E-beam sterilization of aerospace materials: Microbiological & mechanical property evaluations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20191202 |